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Abstract
Parkinson’s disease (PD) is a neurodegenerative disorder that affects more than 1% of the
population, a value that increases exponentially with age. In addition to the motor symptoms,
patients with PD experience several non-motor symptoms, such as auditory deficits and anxiety.
Auditory regularity processing, which is the ability to automatically extract and utilize regular
patterns within a scene is suspected to be impaired in PD. Moreover, freezing of gait (FOG) is a
motor symptom that affects a fairly automatic process, which is gait. We recruited healthy
younger and older participants as well as patients with PD to take part in electroencephalography
(EEG), functional magnetic resonance imaging (fMRI), and gait studies to investigate aspects of
regularity and freezing of gait in PD. Auditory stimuli structures were either random, regular, or a
combination of both. We observed that aging and PD significantly impair regularity processing;
however, PD did not have any additional detrimental effect on regularity processing.
Furthermore, the dopaminergic system impaired regularity processing by reducing the EEG brain
response associated with regularity processing and by reducing fMRI brain activity in areas
linked to regularity processing. It is important to note that the difference found was only observed
when passively listening to the auditory stimulus and not when actively attending to it. The
additional impairment associated with the dopaminergic system might be attributed to the
connections of the ventral tegmental area and its down-stream connections, thus supporting the
dopamine overdose hypothesis. We also proposed a new way to reduce FOG in PD patients using
Alprazolam, a known anxiolytic. Reducing anxiety resulted in an increase in swing time and a
decrease in gait variability, factors linked to more stable and better gait. Given that Alprazolam
managed to reduce anxiety and improve FOG symptoms, we can conclude that anxiety is a causal
factor for FOG. More importantly, we advise a new method to target FOG, which can reduce falls
and incapacitation and overall, improve the patients’ quality of life.

Keywords
Regularity Processing, Parkinson’s Disease, Auditory System, Dopaminergic system, Freezing of
Gait, virtual reality, Alprazolam.
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Summary for Lay Audience
Parkinson’s is a disease that affects approximately 1% of the population. This disease is
characterized by motor (such as tremor) and non-motor symptoms such as impairments in the
auditory system and anxiety. The ability to use regular patterns in the auditory stream is referred
to as regularity processing. In our studies, we found that regularity processing is impaired in
older participants and in patients with Parkinson’s. Moreover, administering levodopa, which is
the main medication used to treat Parkinson’s disease, resulted in alteration in brain activity
associated with regularity processing, supposedly worsening regularity processing. Additionally,
we investigated the effect of reducing anxiety on freezing of gait in Parkinson’s. Freezing of gait
is a symptom experienced by some patients with Parkinson’s in which patients feel that their feet
are glued to the floor. We advised a new way using anxiety medication to reduce anxiety and
improve freezing symptoms in these patients. This reduction can be the first step in finding
medications that efficiently reduce freezing and hence reduces the chances of falls and improves
patient’s quality of life. In conclusion, we found that the dopaminergic system can be involved in
regularity processing and levodopa can have negative effects on that process. Moreover, we
observed a direct link between anxiety and freezing of gait and we also found a new way to
improve that debilitating symptom.
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1

General Introduction:
Parkinson’s disease

Neurodegenerative disorders affect many people each year. Parkinson’s disease (PD) is a
neurodegenerative disorder that affects more than 1% of population, second in number
only to Alzheimer’s disease (Jankovic, 2008; Lees, Hardy, & Revesz, 2009; WilliamsGray, 2016). PD, in its essence, is considered to be a motor disease; however, non-motor
symptoms can be present as well. These symptoms arise due to the depletion of dopamine
in the brain. Temporal processing related to automatic auditory perception and is
suggested to be impaired in PD and might affect their general auditory scene analysis
(Artieda, Pastor, Lacruz, & Obeso, 1992; Harrington, Haaland, & Hermanowicz, 1998).
Moreover, non-motor symptoms in PD (such as anxiety) might have an effect on gait,
another automatic process. This thesis examines the circuitry underlying detection of
regularity and production of regular gait via investigating the roles of aging, PD, and the
dopaminergic system separately using different electrophysiological and imaging
techniques as well as gait assessments.
Neurodegeneration in PD affects mostly the dopamine producing cells in substantia nigra
pars compacta (SNc), an integral part of the basal ganglia, which in turn results in a
reduction in dopamine levels. Deposition of intraneural aggregates of α-synuclein in
Lewy bodies and Lewy neurites is an additional defining pathophysiological feature of
PD. Due to the presence of -synuclein in the Lewy bodies, PD is considered to be an synucleinopathy. furthermore, reduction in dopamine due to the nigrostriatal degeneration
is responsible for PD’s cardinal motor symptoms (resting tremor, bradykinesia, rigidity,
and postural and gait impairment) (Halliday & McCann, 2010; Jankovic, 2008).
Traditionally, PD was defined by motor symptoms, however, it is now considered to be a
complex condition that includes diverse non-motor symptoms. These non-motor
symptoms include cognitive impairment (Aarsland, 2016; B. Dubois & Pillon, 1996;
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Bruno Dubois & Pillon, 1996; Fonseca, Tedrus, Letro, & Bossoni, 2009; Güntekin et al.,
2018; Shohamy, Myers, Grossman, Sage, & Gluck, 2005; Williams-Gray et al., 2009),
sleep disorders such as REM sleep behavior disorder (RBD) (Boeve, 2010; Ferreira,
Prabhakar, & Kharbanda, 2014; Hobson et al., 2002; Olson, Boeve, & Silber, 2000; Paus
& Brecht, 2003; St Louis & Boeve, 2017; Tandberg, Larsen, & Karlsen, 1999; Weintraub
& Burn, 2011a), psychiatric disorders such as anxiety, depression, and apathy (Beck &
Clark, 1988; Carey et al., 2021; Eysenck, Derakshan, Santos, & Calvo, 2007; Overton &
Coizet, 2020; Prediger, Matheus, Schwarzbold, Lima, & Vital, 2012; Quelhas & Costa,
2009; Walsh & Bennett, 2001), and autonomic dysfunction and akathisia (inner
restlessness) (Jankovic, 2008).
Although motor symptoms of PD are the main diagnostic features of the disease, the
heterogeneous nature of PD (i.e., the motor and non-motor symptoms) suggests a
multifactorial causation. Previous studies have found environmental, genetic, and
idiopathic factors that indirectly cause PD progression (William Dauer & Przedborski,
2003; Jankovic, 2008). Unfortunately, diagnosing PD depends on the presence of visible
symptoms (e.g., tremor or rigidity), which usually indicates that a significant and nonreversible degeneration of the SNc has already happened (Fearnley & Lees, 1991).
Currently, there is no cure for PD and treatments are mostly targeted to reduce the motor
symptoms and to improve patients’ quality of life. These treatments range from oral
dopamine replacement to surgical interventions, depending on the patient responsiveness
to treatment and disease stage.

1.1.1

The basal ganglia:

Dopamine is an important modulator of basal ganglia function. The basal ganglia are
composed primarily of the striatum, along with structures such as the subthalamic nucleus
(STN), substantia nigra (SN), and globus pallidus. The striatum is divided functionally
into the dorsal striatum and ventral striatum (DS and VS, respectively). The DS is
composed of the dorsal parts of the caudate and putamen, while the VS is composed of
the nucleus accumbens and the ventral parts of the caudate and putamen (Lanciego,
Luquin, & Obeso, 2012). The basal ganglia are responsible for voluntary motor functions
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as well as procedural learning, working memory, and other aspects of cognition
(Alexander, DeLong, & Strick, 1986).
The basal ganglia via its connection to other cortical and subcortical areas subserve
different functions. As identified in the parallel-circuit hypothesis, the basal ganglia input
and output connections, known as cortico-basal ganglia-thalamocortical circuits, are
believed to support skeletomotor, associative, and limbic functions (Wichmann, DeLong,
Guridi, & Obeso, 2011). Three pathways govern the basal ganglia striatal output: the
direct, indirect, and hyperdirect pathways. The direct pathway connects the medium spiny
neurons (MSNs) of the striatum to the globus pallidus internus (GPi) and substantia nigra
pars reticulata (SNr). The direct pathway is monosynaptic and inhibitory in nature at the
level of the thalamus with a main net effect of activating the motor cortex and initiating
movement. In contrast, the indirect pathway, which originates from a separate population
of MSNs, is polysynaptic and sends inhibitory connections to the neurons in the external
pallidal segment (GPe) which then sends inhibitory connections to the GPi/SNr either
directly or via the STN, with a net effect of inhibiting movement. The hyperdirect
pathway connects the cortex to the GPi via the STN directly and with similar polarity to
the indirect pathway, thus inhibiting movement (Alexander et al., 1986; Wichmann et al.,
2011).
Neuronal loss in PD does not result in clinical symptoms until more than 60% of the
neurons are already degenerated (Fearnley & Lees, 1991; Gotham, Brown, & Marsden,
1984; Marsden, 1990). The pattern of degeneration in PD is unique in that the DS
degenerates faster than the VS (William Dauer & Przedborski, 2003). This in turn results
in the motor symptoms mentioned earlier. Later, degeneration affects the VS and related
areas. Dopaminergic medication ameliorates the symptoms related to the DS (e.g., motor
symptoms), but it can be detrimental to VS related symptoms (William Dauer &
Przedborski, 2003), a phenomenon known as the dopamine overdose hypothesis (Cools,
2006).

4

1.1.2

PD treatments:

PD can only be confirmed after symptoms appear. No biomarkers exist for a more
conclusive diagnosis; thus, therapies are limited to symptomatic control. Current therapies
in PD target motor symptoms through pharmacological and/or surgical interventions. LDopa (L-3,4-dihydroxyphenylalanine) is prescribed to PD patients to replenish the lost
dopamine. Carbidopa is often given in addition to L-Dopa to reduce its metabolism in the
bloodstream, thus increasing the concentration of dopamine reaching the brain and
increasing its effectiveness. Another option is dopamine agonists (such as pramipexole
dihydrochloride), which has similar effects to L-Dopa and can be given with L-Dopa
simultaneously.
The use of dopamine agonists depends on the patient’s age, symptoms presentation,
disease stage, and tolerability of L-Dopa. Some clinicians prefer dopamine agonists as the
first-line of treatment versus L-Dopa, because of the known side effects of the latter
(Williams-Gray & Worth, 2016). Surgical interventions can also be an option for patients
with PD. Deep brain stimulation (DBS) of the STN, globus pallidus internus, or ventral
intermediate nucleus of the thalamus is one the most available and invasive surgical
interventions for PD patients.
In addition to the motor and cognitive symptoms, patients with PD have noticeable
changes in their auditory processing ability, for example beat perception (Cameron,
Pickett, Earhart, & Grahn, 2016) and speech perception (Kwan & Whitehill, 2011). These
changes may stem from aging, with aging being related to auditory deficits, or from PDrelated neurodegeneration. Furthermore, L-Dopa also affects auditory processing in PD
(Weis, Puschmann, Brechmann, & Thiel, 2017). But how exactly is the auditory system
affected by aging and PD and how can medication (L-Dopa) affect regularity processing?

The auditory system
The auditory system is comprised of peripheral structures and brain regions that work
together to enable us to hear and understand sounds, such as music and language. The
peripheral region includes the outer-, middle-, and inner-ear, while the brain regions in the
auditory pathway start from the cochlear nuclei and progress through the superior olivary
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nuclei, lateral lemniscus, inferior colliculus, medial geniculate body, and the auditory
cortex. These brain regions are involved in frequency encoding, sound localization,
processing, understanding, and properly interpreting sounds.
The primary auditory cortex is composed of the superior temporal gyrus (STG) which is
responsible for the sensation and categorization of sounds based on spectral (pitch) and
temporal (rhythmic) features. Surrounding the primary auditory cortex is the secondary
auditory cortex, which processes more complex combinations of features than primary
auditory cortex and is interconnected with the primary auditory cortex and frontal areas.
The connections between the auditory areas are important for speech perception and
comprehension. Furthermore, the frontotemporal connections aid in auditory scene
analysis along with speech comprehension and production, and further distinction
between sound and noise (Auerbach & Gritton, 2022).

Auditory scene analysis
The auditory system is expected, and usually is successful, in perceiving different
auditory stimuli. We use auditory cues to disentangle concurrent sounds into meaningful
auditory information, a process known as auditory scene analysis (Bregman, 1990). For a
second, think of the number of auditory signals arriving at your ears each second. Of
those, how many are relevant to the task in hand? How many are automatically
processed? And how many require conscious awareness? The ability to decipher these
signals into meaningful information by the brain is what auditory scene analysis means.
From auditory signals we can figure out the location of the sound, how far is that sound,
how loud is that sound, and finally we can instantly know if someone mentions our name.
Needless to say, this ability is essential for survival.
We can perceive sounds based on different components, for example, similarity: the
auditory system groups stimuli based on how similar sounds are in terms of loudness,
pitch, and timbre. Continuation is another component that our brain uses to perceive
auditory stimuli: in this feature, smooth continuation of an auditory stimulus versus abrupt
changes helps us decide whether these sounds are a single event or different events,
respectively. Moreover, the principle of common fate means that when sounds start or end
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at the same time, we tend to group them together in the auditory scene. The principles of
disjoint allocation and closure can also assist in the stream segregation for an optimal
behavioral outcome (Susan L. Denham & Winkler, 2015). Taken together, the presence of
these components allows for better auditory stream segregation; however, perceiving
these sounds requires the interplay of different brain areas.
Auditory scene analysis, according to Bregman’s theory, is subdivided into two phases,
the first being the formation of alternative sounds and the second being the selection
amongst alternatives to be perceived. In other words, listeners learn the abstract structure
of novel sounds and disentangle the concomitant sounds by using these learned structures.
Thus, the auditory scene analysis uses stimulus driven (bottom-up) and learning and
memory (top-down) to perceive and tease apart different auditory structure in a busy
scene (Winkler, Denham, & Nelken, 2009; Woods & McDermott, 2018).
Incidentally, one thing that optimizes auditory scene analysis and stream segregation is
the presence of regularity in those streams. The ability to learn auditory regularities to
improve perception is known as regularity processing (Gifford et al., 2019; Kondo, Van
Loon, Kawahara, & Moore, 2017; Southwell, Baumann, Gal, Barascud, Friston, et al.,
2017).

Regularity processing
Humans are sensitive to the presence of regularities within the visual, auditory, and tactile
systems. In the auditory system particularly, the presence of these regularities helps in
understanding the global auditory scene and making decisions related to those scenes. For
example, as a listener, regularity enables you to identify information about auditory
stimuli such as footsteps near you, an ambulance passing by, train sounds on the rails, or
the clapping sounds in a party. More importantly, listeners can, as part of the auditory
scene analysis, extract relevant information using these regular patterns to process these
sounds (Bendixen, Schröger, Ritter, & Winkler, 2012).
To perceive an auditory change in the global scene requires the extraction of regularities
from these sounds, against which new inputs are compared (Bendixen, Roeber, &
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Schröger, 2007a). The importance of predictability and regularity, terms that will
henceforth be used interchangeably, in the auditory system are essential in tasks such as
speech comprehension, beat perception, and behavioral responses to sound. Hence, it is
essential to understand how our brain perceive regularities and how we exploit these
regularities for optimal behavior. That is why, being able to detect the brain changes
associated with regularity, experimentally, can give us a window on understanding how
aging and other neurodegenerative disorders affect this ability.

1.4.1

How is regularity processing detected?

The primary way that regularity processing is measured is by using
electroencephalography (EEG), traditionally using mismatched negativity, because of its
high temporal resolution. Unfortunately, EEG alone does not have the spatial resolution to
isolate specific brain regions associated with regularity processing. Techniques such as
magnetoencephalography (MEG) are better for source localization. For the best spatial
resolution, functional magnetic resonance imaging (fMRI) can be implemented to better
understand the specific brain regions associated with regularity processing (Aman,
Picken, Andreou, & Chait, 2021; Barascud, Pearce, Griffiths, Friston, & Chait, 2016;
Southwell, Baumann, Gal, Barascud, Friston, et al., 2017).

1.4.2

The MMN and deviant detection

The mismatch negativity (MMN), a particular event related potential (ERP), has been
used extensively to investigate deviant detection with EEG. In addition to deviant
detection, the MMN has been used to investigate pattern processing in the auditory stream
(Nordby, Roth, & Pfefferbaum, 1988; Rimmele, Sussman, & Poeppel, 2015a; Van Zuijen,
Sussman, Winkler, Näätänen, & Tervaniemi, 2005). The MMN results from the violation
of a standard stimulus. This violation can occur as a temporal change (e.g., stimulus
duration) or other physical change (e.g., a change in frequency or timbre). In addition,
MMN can be elicited via the violation of a regularity within an auditory stimulus
(Bendixen et al., 2013; Getzmann & Näätänen, 2015; Näätänen, Paavilainen, Rinne, &
Alho, 2007; Näätänen et al., 2011; Rimmele, Sussman, & Poeppel, 2015b; Rimmele,
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Schröger, & Bendixen, 2012; Sussman, Wong, Horváth, Winkler, & Wang, 2007; van
Zuijen, Sussman, Winkler, Näätänen, & Tervaniemi, 2005; Van Zuijen et al., 2005).
The MMN is considered an automatic response, as it can be elicited during passive
listening, or even listening while performing a different task, also called “ignore”
listening; however, Sussman et al., (2007) suggested that MMN requires attention in
certain cases. Eliciting the MMN requires the contribution of two different brain regions:
the auditory cortices (bilaterally) and the frontal cortices (predominantly right
hemisphere) (Näätänen et al., 2007). It is believed that the auditory cortex is involved in
the rapid detection of change, or regularity violation. In contrast, the frontal cortices
appear to be related to the violation-related involuntary switching of attention to relevant
and important events that occur with MMN. Although spatial resolution is not high in
EEG studies, fMRI studies on regularity violation have shown a an involvement of the
frontal areas in addition to the primary and secondary auditory areas (Alexandra Bendixen
et al., 2012; Escera, Leung, & Grimm, 2014; Malmierca, Sanchez-Vives, Escera, &
Bendixen, 2014; Van Zuijen et al., 2005).

1.4.3

The sustained response in regularity processing

In addition to the MMN, a different EEG measure, called the sustained response, has been
used to study auditory regularity processing. The sustained response was first reported by
Barascud et al. (2016). They created a regular stimulus and showed that increases in the
sustained response correlated with the perception of regularity. Participants passively
listened to auditory stimuli constituted of short tone pips (40 ms) with pitches that were
either randomly selected or repeated in a regular pattern. For the random condition,
different frequencies were heard with no reliable pattern. For the regular pattern
condition, the pitches of the tone pips (total of 5, 10, 15, or 20 tone pips) repeated 10
times such that a regular pattern could be detected. The transitions between these stimulus
conditions were manipulated, with random sometimes transitioning to regular and vice
versa. The random and regular auditory stimuli were presented in MEG and fMRI tasks.
The sustained response is characterized by an increase in the DC power that immediately
follows the MMN response and plateaus until the stimulus is over. This increase in the
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sustained response is concomitant with the emergence of a regular structure in the
auditory stimulus. In contrast, the sustained response decreases when the stimulus
changes from a regular to a random one. Thus, the presence of regularity can be detected
via EEG and shows an enhancement of the sustained response (Barascud et al., 2016;
Sohoglu & Chait, 2016; Southwell, Baumann, Gal, Barascud, Friston, et al., 2017)
During the MEG experiment, participants passively listened to the auditory stimuli while
attending to a different visual task. Stimuli were either random, random transitioning to
regular, regular, or regular transitioning to random. It was found that transitioning from
random to regular resulted in an increase in the sustained response. In contrast, the
transition to randomness was associated with a significant drop in MEG response (Fig.
1.1).

Figure adopted from Barascud et al., (2016).
Figure 1.1: MEG response, presented as root mean square (RMS) of random and regular auditory stimuli.
Stimuli were either random (RAND), random transitioning to regular (RAND-REG), regular transitioning to
random (REG-RAND), or regular (REG). Following the transition, REG stimuli resulted in an enhancement
in the sustained response. RAND stimuli, in contrast, resulted in a decrease in the sustained response.
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In their second experiment, fMRI was used to investigate specific areas associated with
regularity processing. Participants attended to a visual N-back task while passively
listening to auditory stimuli. The stimuli in this case were either random or regular only.
Combining the MEG and fMRI studies, the authors concluded that areas involved in
regularity processing (i.e., that responded more to regular than random) include, but are
not limited to, the STG bilaterally and the right inferior frontal gyrus (IFG). Additionally,
the involvement of the hippocampus was reported in their study.

Importance of regularity processing
The occurrence of regularities, even in multi-frequency auditory stimuli, improves target
detection and increases detection accuracy of embedded targets. Sussman and colleagues
(2006) found that temporal regularity facilitates perceptual segregation. Embedding
regular auditory stimuli within a busy environment improved the listeners’ ability to
attend to the sequence. Moreover, regularity improves perception, both when regularity is
within the target stream or when present in the background noise. Change detection
improves when the target is regular and to some extent when the noise is regular (Aman et
al., 2021). Therefore, listeners end up coding local (target) and global (background)
regularities that can be exploited in both foreground and background to optimize
perception and behavior.
In a different MEG study, Sohoglu & Chait (2016) demonstrated that not only appearance
but also the disappearance of regularities affects auditory scene perception. In their study,
the transition from random to regular increased brain activity in the auditory cortex (STG
and planum temporale) and the superior parietal lobe. Additionally, attending to the
auditory stimuli increased the latency and decreased the amplitude difference between
regular and random. Active listening managed to reduce the surprise associated with the
change detection.
The presence of regularities, along with the ability to perceive these regularities, is
essential to optimize stream segregation. However, auditory stream segregation ability can
be impaired by aging (Henry, Herrmann, Kunke, & Obleser, 2017; Herrmann, Buckland,
& Johnsrude, 2019a; Herrmann, Henry, Johnsrude, & Obleser, 2016). Therefore, how
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aging affects regularity processing and stream segregation is an important avenue to
explore.
Additionally, PD affects the auditory system especially with speech comprehension (De
Keyser et al., 2016; Gräber, Hertrich, Daum, Spieker, & Ackermann, 2002) and temporal
processing (Artieda et al., 1992; Harrington et al., 1998). However, L-Dopa does not
have a clear effect on this ability, with evidence supporting a role that worsens (Artieda et
al., 1992) or improves (Rammsayer & Classen, 1997) temporal processing ability.
The importance of auditory scene analysis and stream segregation and the decline of this
ability in aging (Getzmann & Näätänen, 2015; Risto Näätänen et al., 2011; Rimmele,
Schroger, & Bendixen, 2012), and the role of the dopaminergic system (Te Woerd,
Oostenveld, de Lange, & Praamstra, 2018; Te Woerd, Oostenveld, De Lange, &
Praamstra, 2017) will be the scope of studies in chapters 2 and 3 of this thesis using EEG
and fMRI, respectively.

Relation between the auditory system and gait
Sound and movement are inherently linked. This can be most obviously seen in the
development of speech, in which the sounds we hear are used to refine the speech
movements we make. But sound can also induce spontaneous movement in the context of
music and dance, and regularity in rhythm engages the motor system (Chen, Penhune, &
Zatorre, 2008; Grahn & Brett, 2007; Kung, Chen, Zatorre, & Penhune, 2013), even when
no actual movement is made. Moreover, playing a regular metronome or music with a
steady beat has been shown to improve gait in various disorders. Hence, the auditory
system is intrinsically linked to the motor system and targeting the auditory system with
regular stimuli to improve gait has shown some success.
The role of rhythmic auditory stimulation (RAS) has been studied extensively to
investigate its effect on gait, especially in populations with PD, cerebellar stroke, and
Alzheimer’s disease. RAS and other auditory cueing approaches improve gait
disturbances associated with PD, for instance freezing of gait (FOG) (Baker, Rochester, &
Nieuwboer, 2007; Chester, Turnbull, & Kozey, 2006; Delval et al., 2014; Guimarães et
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al., 2015; Karim, Rumalla, King, & Hullar, 2018; Lee, Yoo, Ryu, Park, & Chung, 2012;
Mcintosh, Brown, Rice, & Thaut, 1997; Park et al., 2014; Suteerawattananon, Morris,
Etnyre, Jankovic, & Protas, 2004; Yu et al., 2015). In addition, several gait measures (e.g.,
variability reduction or stride length increase) improved following the introduction of
auditory cueing. The simplest auditory cueing approach uses a metronome set at 10-15%
faster than the participants’ baseline walking rate and asks participants to sync to the
metronome. Most of these studies have found an improvement in different spatial and
temporal gait parameters as well as gait variability. When comparing medication states,
PD patients have demonstrated a noticeable improvement in gait during auditory cueing
while on and even while off medication (Chester et al., 2006).
Gait variability is an important indicator of gait stability. In general, higher gait variability
(particularly in step-length, -time, and -velocity) predisposes healthy older adults and
neurodegenerative patients to the risk of falls, which may result in incapacitation and
decrease quality of life. Thus, decreasing step time variability and double support time
leads to an improvement in gait, which could significantly reduce the chance of falling
(Wright, Bevins, Pratt, Sackley, & Wing, 2016). As mentioned earlier, RAS reduces
stride-to-stride variability (Hausdorff et al., 2007). RAS at 110% of PD patients’ preferred
walking cadence reduced gait variability, which translated to a more rhythmic and
steadier gait by reducing stride time and stride time variability and increasing stride
length. This steadiness in turn, could reduce the chances of falling associated with gait
instability in PD, especially with FOG.
In a case study of a cerebellar stroke patient, auditory cueing had a positive effect on gait
(Wright et al., 2016). Both temporal and spatial gait variability reduced with auditory
cueing. However, auditory cueing is not successful in all neurodegenerative disorders.
Particularly, Alzheimer’s disease patients show a reduction in gait velocity and stride
length, and an increase in stride length variability (Wittwer, Webster, & Hill, 2013), all
indicators of impaired gait and predictors of falling.
In summary, the auditory system influences gait and could possibly be a contributor to
improving gait. Evidence showing improvements in gait with auditory cueing (Hausdorff
et al., 2007) in addition to other findings (e.g., examining why we tap to a beat; (Cameron
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et al., 2016; Grahn & Brett, 2009; Grahn & Rowe, 2013)) suggest clear interactions
between the auditory and motor systems, and that the basal ganglia may be key to the
influence of regular auditory cues on movement.

The auditory system’s role in gait abnormalities
Beat perception and synchronization deficits may indicate a disrupted auditory to motor
mapping (Sowiński & Dalla Bella, 2013), with the motor system being involved in
perceiving and synchronizing to beats (Tranchant, Lagrois, Bellemare, Schultz, & Peretz,
2021). To further investigate the link between beat perception and the motor system,
Leow, Parrot and Grahn (2014) conducted a study on how poor vs good beat perception
affects gait. Younger adults performed a beat alignment test (BAT) to assess beat
perception ability and walked in different auditory conditions (weak beat, strong beat, and
metronome). Good beat perceivers had faster and more stable gait in both the strong beat
and metronome conditions compared to the weak beat one. This study confirms a link
between the auditory system and gait, where better beat perception ability is correlated
with faster and more stable walking. That study was a stepping-stone in understanding the
link between auditory perception and gait with a direct quantitative measure for both
auditory and gait variables.
It is known that PD patients with FOG experience dysrhythmia of movements. For
example, the presence of freezing is correlated with a pronounced disruption in internal
rhythmic timing, which is the ability to perceive beat and synchronize to external auditory
stimuli (Freeman, Cody, & Schady, 1993). Additionally, PD patients with FOG have
difficulty maintaining internally cued rhythmic motor movements (Tolleson, Dobolyi,
Roman, & Kanoff, 2017).
Regularity processing, due to its bottom-up nature, may be crucial to beat perception as
the common denominator in regular rhythmic motor movement, such as dance, music, and
in our case, gait. In chapters 2 and 3, we will discuss regularity processing in the context
of aging, PD, and the dopaminergic system in general.
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Freezing of gait (FOG) in PD
FOG is a motor symptom in PD that affects more than 50% of PD patients in their later
stages. This symptom is characterized by sudden and transient stops that may result in
falls and significantly reduces the quality of life of PD patients. The pathophysiology
underlying FOG is not fully understood, but it appears to be predicted by anxiety
(Ehgoetz Martens, Ellard, & Almeida, 2014; Ghielen et al., 2020; Giladi, Huber-Mahlin,
Herman, & Hausdorff, 2007; Witt, Ganjavi, & Macdonald, 2019).
Most PD patients experience several psychiatric comorbidities, mainly anxiety and
depression (Beck & Clark, 1988; Chen & Marsh, 2014; Eysenck, Derakshan, Santos, &
Calvo, 2007; Prediger, Matheus, Schwarzbold, Lima, & Vital, 2012; Quelhas & Costa,
2009; Walsh & Bennett, 2001; Weintraub & Burn, 2011). Different models exist to
explain the occurrence of FOG in PD: 1) the threshold model, 2) the decoupling model, 3)
the cognitive model, and 4) the cross-talk model (each will be discussed further in
Chapter 4 and General Discussion). These models serve the purpose of identifying the
underlying causes of FOG and attempt to explain the pathophysiology of freezing. Our
study supports the cross-talk model with the role of anxiety playing a causal factor in
provoking FOG in patients with PD.
Ehgoetz Martens and colleagues (2014) have found a correlation between anxiety and
freezing. Using virtual reality to induce anxiety, they found that with higher anxiety, gait
is slower (lower velocity, shorter step length) and more variable (higher step length and
step time coefficient of variation (CV)). Additionally, FOG frequency and severity
significantly increased with high anxiety virtual scenarios compared to the low anxiety
ones.

1.8.1

Anxiety in PD

One of the most common non-motor symptoms in PD is anxiety, a symptom that is
underdiagnosed in this population. This non-motor disorder affects more than half of PD
patients causing a reduction in quality of life, loss of autonomy, and increase in caregivers
distress (Beck & Clark, 1988; Jack Chen & Marsh, 2014; Prediger et al., 2012; Quelhas &
Costa, 2009; Walsh & Bennett, 2001). Anxiety in PD can take the form of panic
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disorders, social anxiety, or generalized anxiety disorders. In contrast, anxiety can be a
product of neurochemical imbalances occurring with or even preceding PD
neurodegeneration (Prediger et al., 2012).
As mentioned earlier, PD is associated with non-motor symptoms that include sleep
related disorders, psychiatric symptoms (such as psychosis, mood disturbance, anxiety,
and depression) and autonomic dysfunction (Kalia & Lang, 2015a; Lees et al., 2009;
Williams-Gray & Worth, 2016). Anxiety affects more than 31% of PD patients, a
percentage higher than in healthy controls and other neurodegenerative populations.
Anxiety and depression are a few of the psychological comorbidities, with anxiety being a
predictor of worse quality of life, associated with PD (Quelhas & Costa, 2009).

1.8.2

Anxiety treatment in PD

To reduce anxiety in PD, physicians tend to use medications that target the GABAergic
(e.g., benzodiazepines) or serotonergic (e.g., selective serotonin reuptake inhibitors)
systems. Moreover, monoamine oxidase inhibitors can be prescribed, which are effective
in reducing both anxiety and depression (Aarsland & Kramberger, 2015). Nonpharmacological interventions are also available for PD patients with anxiety. For
example, cognitive behavioral therapy has proved effective in the treatment of anxiety as
well as depression in PD (Chen & Marsh, 2014).
Through this thesis, I aim to disentangle the role of regularity processing in aging, PD,
and with respect to L-Dopa (Chapters 2 & 3) and the effect of reducing anxiety on FOG
(Chapter 4). We recruited healthy young controls, healthy older controls, PD patients, and
PD patients with FOG across different studies using various techniques (behavioral, EEG,
fMRI, and gait studies) to answer our questions.

Hypotheses
We hypothesized that regularity processing is affected by aging and PD, with an
additional impairment in the latter group. Additionally, L-Dopa might negatively affect
regularity processing. The possible impairment associated with L-Dopa might be related
to the overdosing of areas that are essential for regularity processing (IFG and
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hippocampus). These areas that receive inputs from the basal ganglia, which also affects
automatic gait, are significantly impaired in PD, suggesting a connection between
automatic regularity processing and gait. Answering the questions related to regularity
processing can be essential to answering why auditory cueing can improve gait in some
neurodegenerative disorders, such as PD. Moreover, this direct link between the auditory
and motor system could be a window to explain the loss of automaticity found in FOG,
which can also be modulated by higher levels of anxiety. Finally, we hypothesized that
reducing anxiety in PD patients would ameliorate FOG symptoms by improving specific
gait variables.
The main objectives for Chapters 2 and 3 were to understand the role of aging, PD, and LDopa in regularity processing, to investigate with high temporal (EEG) and spatial (fMRI)
resolution the areas associated with regularity processing, and finally to improve our
understanding of the auditory stream with respect to PD and gait
In Chapter 2, we investigated regularity processing in aging and in PD. A follow up study
(Chapter 3) investigated the effect of L-Dopa on regularity processing in healthy younger
adults using fMRI. In Chapter 2, we utilized EEG to investigate regularity processingrelated brain responses. To reiterate, previous studies on regularity processing have
implicated the primary auditory cortex and associated auditory areas, in addition to
higher-level cortical areas (such as the IFG and parts of the parietal cortex as well as the
hippocampus). More importantly, these areas receive reciprocal innervation with the basal
ganglia, which is implicated in PD and in aging. Therefore, we expected a deficiency in
regularity processing ability associated with aging and PD, which would be demonstrated
by a reduction in the sustained response. Moreover, we expect that medication will either
worsen regularity processing. The rationale behind these expectations stem from the fact
that the areas involved in regularity processing receive innervation from the basal ganglia,
an area extensively affected in PD. We expect that if the DS and its downward stream
connections are involved in regularity processing, we will see a significant reduction in
the sustained response in PD patients compared to healthy older controls while off
medication. In contrast, if the VS/VTA stream is involved in regularity processing, there
will be a similar reduction in both healthy older controls and PD patients compared to
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healthy younger controls. With medication, if the DS is associated with regularity, we
expect that medication will improve regularity processing in PD patients, seen as an
enhancement in the sustained response. In contrast, if the VS/VTA stream is involved, we
will see a decline in regularity processing when ON medication compared to the OFF
state in PD patients. For this study, 19 PD patients and 19 healthy controls were recruited
to take part in an EEG study on regularity processing. Additionally, we were able to
utilize data from 16 healthy younger controls on the same paradigm. These three cohorts
will help us explain the link between aging, PD, and the dopaminergic system in
regularity processing.
In Chapter 3, we investigated, using fMRI, the specific brain regions involved in
regularity processing. We also investigated the effect of exogenous L-Dopa on brain
activity during regularity processing. Previous studies on regularity found activation of
specific brain areas (e.g., STG, hippocampus, inferior frontal gyrus, and parietal cortex).
Using this approach, we had better spatial resolution to see a medication effect on these
specified brain areas. As a continuation of the first study (Chapter 2), the rationale is
similar. We predicted that healthy younger controls would differ in brain activity when
comparing ON and OFF medication. In the fMRI study, 17 healthy younger controls took
a part.
The possible impairment in regularity processing in the auditory stream might be one of
the underlying reasons causing FOG; however, there is evidence that other factors play a
role in provoking FOG in PD. Therefore, the main objective of Chapter 4 was to find a
new method to tackle FOG in PD patients. Chapter 4 tested the effect of reducing anxiety
on FOG in PD patients. Using virtual reality to induce anxiety in PD patients experiencing
FOG, we investigated the effect of alprazolam (a fast-acting anxiolytic benzodiazepine
medication) on FOG. It was found previously that anxiety is correlated with FOG, but our
approach attempts to find a causal link between anxiety and FOG. Ten PD patients with
FOG were tested twice, one week apart, once on alprazolam (0.25 mg) and once on
placebo (corn starch). Patients walked in four different conditions, the first being the
baseline which was regular walking without the virtual reality setup. The remaining three
conditions took place in virtual environments based on a “walk-the-plank” task. The first
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virtual scenario was a low anxiety one, where patients walked in a virtual environment
that had a plank level with the floor. This condition was included to control for the effect
of virtual reality environment on patients’ gait. The second virtual scenario was a high
anxiety one, where there was a deep pit next to the plank. Finally, the third scenario was
also a high anxiety one, but in this scenario the plank was elevated to an anxiety
provoking level. We hypothesized that reducing anxiety using alprazolam in an anxietyprovoking scenario would reduce anxiety. This reduction in turn would translate into
fewer and less severe FOG episodes. Additionally, we expected that FOG parameters
associated with freezing, such as slower and more variable gait, would improve following
the administration of alprazolam. This will be an important study examining how anxiety
induces FOG, with clinical implications for treating FOG in PD patients.
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The effect of aging, Parkinson’s disease, and exogenous dopamine
on the neural response associated with auditory regularity processing

2

Processing regular patterns in auditory scenes is important for navigating complex environments.
Electroencephalography (EEG) studies find enhancement of sustained brain activity, correlating
with the emergence of a regular pattern in sounds. How aging, aging-related diseases such as
Parkinson’s disease (PD), and treatment of PD with dopaminergic therapy affect this fundamental
function remain unknown. We addressed this knowledge gap. Healthy younger and older adults,
and PD patients listened to sounds that contained or were devoid of regular patterns. Healthy
older adults and PD patients were tested twice—off and on dopaminergic medication, in
counterbalanced order. Regularity-evoked, sustained EEG activity was reduced in older,
compared to younger adults. PD patients and older controls evidenced comparable attenuation of
the sustained response. Dopaminergic therapy further weakened the sustained response in both
older controls and PD patients. These findings suggest that fundamental regularity processing is
impacted by aging but not specifically by PD. The finding that dopaminergic therapy attenuates
rather than improves the sustained response coheres with the dopamine overdose response and is
in line with previous findings that regularity processing implicates brain regions receiving
dopamine from the ventral tegmental area that is relatively spared in PD and normal aging.
Keywords: Regularity processing, Auditory scene analysis, Parkinson’s disease
A version of this chapter has been published in Neurobiology of Aging.
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Introduction
Auditory scene analysis is the ability to perceptually organize superimposed sounds (i.e.,
a sound mixture) into meaningful streams, such as a person’s voice or an approaching car
(Bregman, 1990a). Regular patterns in sounds support perceptual organization as they
enable a listener to a) track a sound over time while relegating to the background nonpatterned, irrelevant sounds (Griffiths, Büchel, Frackowiak, & Patterson, 1998; Winkler et
al., 2009), b) predict future events (Barlow, 2001; A. Bendixen, Schroger, & Winkler,
2009; S. L. Denham & Winkler, 2006; Sloutsky, 2003; Sohoglu & Chait, 2016; TurkBrowne, Scholl, Chun, & Johnson, 2009), and c) efficiently organize the auditory scenes
(Andreou, Kashino, & Chait, 2011; Alexandra Bendixen, Roeber, & Schröger, 2007b;
Christiansen, 2014).
One line of research that focuses on the processing of regular patterns showed that when
listeners are exposed to sounds a) containing a regular amplitude or frequency modulation
(Herrmann, Buckland, & Johnsrude, 2019b; Herrmann & Johnsrude, 2018b), b) made of
chords (Teki et al., 2016), or c) composed of repeating tones (Sohoglu & Chait, 2016;
Southwell, Baumann, Gal, Barascud, & Friston, 2017), a low-frequency sustained neural
response is elicited in electroencephalography (EEG) or magnetoencephalography (MEG)
recordings, relative to the neural response to a sound without a regular pattern (i.e., a
random sequence). Further, using MEG and functional magnetic resonance imaging
(fMRI), regular relative to random patterns have shown preferential brain activation in
hippocampus, superior temporal gyrus, and inferior frontal gyrus (Barascud, Pearce,
Griffiths, Friston, & Chait, 2016b). Consequently, the detection of regular patterns in
sounds appears to rely on a variety of cortical structures in addition to auditory cortex
(Lütkenhöner, Seither-preisler, Krumbholz, & Patterson, 2011) that support higher-level
functions. In addition, the stratification of the auditory stimuli in these studies, (i.e., using
stimuli with different repetition iteration) have resulted in different amplitude increases
that correlate with behavioural changes (Barascud et al., 2016b; Southwell, Baumann,
Gal, Barascud, & Friston, 2017). The magnitude of the sustained response seems an
important indicator of regularity processing ability. Behaviourally, participants’ ability to
detect the transition of auditory stimuli from random to regular and vice versa associates

35

with the neural response dynamics obtained via MEG and fMRI indicating a rapid
recognition of regularity (Barascud et al., 2016).
Aging and neurodegenerative disorders are speculated to interfere with regularity
processing. Previous investigations of auditory scene analysis in aging have revealed
difficulty for the aging population to temporally segregate simultaneous auditory stimuli
(Alain, Ogawa, & Woods, 1996; Harris & Dubno, 2017) as well as difficulty indetecting
auditory deviance (Aghamolaei et al., 2018). In addition, it has been suggested that aging
might affect speech perception and comprehension due to impairment in auditory
processing resulting in the reallocation of mental resources towards identifying words,
compromising the understanding and evocation of meaning of that word (Pichora-Fuller,
2003). Other studies have identified deficits, such as loss of temporal precision (Anderson,
Parbery-Clark, White-Schwoch, & Kraus, 2012), or of automatic discrimination
(Getzmann & Näätänen, 2015) in auditory scene analysis. These studies suggest a
deficiency in temporal processing related to detecting regularities in the aging population.
Furthermore, Herrmann et al., (2019) suggested that the reduction of the sustained
response amplitude related to aging might be due to distinct representation of regularity in
sounds to the auditory cortex with underrepresentation in higher-level brain regions that
are usually involved in temporal regularity processing.
Interestingly, patients with Parkinson’s disease (PD) are also impaired in temporally
segregating auditory stimuli and have deficiency in auditory-to-motor synchronization
(Meijer, te Woerd, & Praamstra, 2016; Te Woerd et al., 2018). These findings suggest that
PD might be associated with a deficiency in temporal processing within scenes (Guehl et
al., 2008). No studies to this point have directly investigated whether there are
impairments in regularity procressing in PD.
PD is a common, debilitating neurodegenerative disease that principally affects the basal
ganglia, a collection of sub-cortical nuclei that control movement and aspects of cognition
(W Dauer & Przedborski, 2003; Hirsch, Jette, Frolkis, Steeves, & Pringsheim, 2016). In
PD, there is profound loss of dopamine-producing neurons in the substantia nigra pars
compacta (SNc) with relative sparing of the dopamine-producing in the neuros of the
ventral tegmental area (VTA). The SNc provides dopamine to the dorsal aspect of the
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striatum (DS) comprising the bulk of the caudate nucleus and putamen, whereas the VTA
supplies the ventral striatum (VS), composed of the nucleus accumbens and the most
ventral parts of the caudate and putamen, as well as limbic and prefrontal cortices.
Dopamine deficiency to the DS produces the cardinal motor manifestations of PD
including bradykinesia (i.e., slowness of movement), resting tremor, and muscular rigidity
(Dauer & Przedborski, 2003), as well as cognitive deficits in cognitive control such as
impairments in attentional shifting, response inhibition, and task switching (P. A.
MacDonald & Monchi, 2011; Solís-Vivanco et al., 2011). In contrast, the VTA is
relatively spared in PD and therefore functions mediated by brain regions receiving
dopamine from the VTA are intact until later stages of PD. This is because VTA
degeneration progresses slowly over PD evolution.
Consistent with the presumed pathophysiological basis for these motor and cognitive
deficits in PD, L-3,4-dihydroxyphenylalanine (L-dopa), a dopamine precursor that crosses
the blood-brain barrier, and dopamine agonist medications, improve these motor
(Birkmayer & Hornykiewicz, 1961; Cotzias, Papavasiliou, & Gellene, 1969) and
cognitive functions (Beigi, Wilkinson, Gobet, Parton, & Jahanshahi, 2016; Kwak, Müller,
Bohnen, Dayalu, & Seidler, 2010; MacDonald et al., 2014; MacDonald & Monchi, 2011).
In contrast, dopaminergic therapy actually overdoses brain regions receiving dopamine
from the relatively-spared VTA, worsening functions performed by these brain regions
(Gotham et al., 1988; for reviews please see Cools 2006; Macdonald & Monchi 2011). In
addition to the better-known side effects of dopaminergic medication, such as dyskinesias,
hallucinations, and other psychotic symptoms that occur in later-staged PD patients who
are receiving higher doses of dopaminergic therapy (Alzahrani & Venneri, 2015; Barrett
et al., 2017; Ecker, Unrath, Kassubek, & Sabolek, 2009; Fénelon & Alves, 2010;
Pagonabarraga et al., 2014; Papapetropoulos & Mash, 2005), there is a substantial
literature detailing the detrimental effects of even low doses of dopaminergic therapy, on
early-to-mid-stage PD patients on cognition (for reviews see Cools, 2006; Macdonald and
Monchi, 2011) and behaviour (e.g., impulse control problems; Antonelli et al., 2014,
2011; Pine et al., 2010; St. Onge and Floresco, 2009; Van Eimeren et al., 2009). The
effect of dopaminergic therapy on regularity processing has not to this point been studied
directly.
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Here, we implemented a protocol that has recently been used to investigate auditory
regularity processing (Barascud et al., 2016; Chait, Poeppel, de Cheveigne, & Simon,
2007; Heilbron & Chait, 2018; Sohoglu & Chait, 2016; Southwell, Baumann, Gal,
Barascud, & Friston, 2017). The typical approach is to measure, with EEG or MEG, a) the
neural response during the transition of auditory tones from a random to a regular pattern,
compared to b) the neural response for random tones presented throughout the trial (i.e.,
REG-minus-RAND). The enhancement in amplitude of the EEG or MEG neural response
for REG compared to RAND conditions has been taken as evidence that the brain detects
an auditory pattern. This task is typically performed passively without an explicit or
behavioural response while participants focus on and respond in a more engaging,
primary task (Barascud et al., 2016b). This design arose due to an expectation that
regularity processing, particularly in the auditory domain, is an implicit or automatic
process (Alexandra Bendixen et al., 2007b; Van Zuijen et al., 2005; Winkler et al., 2009).
This view seems to be supported by the consistent finding of a neural sustained response
emerging before two full cycles of regular relative to random auditory sequences are
completed, even when participants engage in demanding primary tasks and ignore the
auditory tones (Barascud et al., 2016; Heilbron & Chait, 2018; Southwell, Baumann, Gal,
Barascud, & Friston, 2017; Teki et al., 2016). Barascud et al., (2016) sought to validate
that the sustained neural response corresponded to behavioural and psychological
phenomena. Toward that goal, they asked participants to make an explicit manual
response as soon as they perceived a pattern among the otherwise random auditory tones.
After establishing robust neurophysiological correlates for regularity processing and using
ideal Bayesian assumptions, Barascud et al. (2016) set the scaffold for further research on
regularity processing with a clear systematic approach coupling an explicit response with
an otherwise typical tone listening paradigm. This study revealed correspondence between
the neural sustained response using EEG and the explicit manual response indicating
detection and awareness of regularity. This study confirmed that the neural sustained
response is a valid and reliable measure of successful perception of onset of regularity in
auditory tones.
Finally, though we investigated regularity detection in the auditory domain in this study,
regularity processing underlies many cognitive functions in all modalities (Chennu et al.,
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2013; Summerfield & De Lange, 2014). Regularity processing is a prerequisite for
auditory scene analysis (Sohoglu & Chait, 2016), as well as learning patterns and
associations in general, not constrained to the auditory modality (Alexandra Bendixen et
al., 2007b; Winkler et al., 2009). Diverse cognitive functions that incorporate or depend
upon intact regularity processing are known to be affected by advancing age (Bettio,
Rajendran, & Gil-Mohapel, 2017; Gazzaley, Cooney, Rissman, & D’Esposito, 2005;
McGeer, McGeer, & Suzuki, 1977), PD (for reviews see Cools, 2006; Macdonald and
Monchi, 2011), and dopaminergic therapy (for reviews see Cools, 2006; Macdonald and
Monchi, 2011). For example, speech processing (Anderson et al., 2012) and auditory
stream segregation (Dinces & Sussman, 2017; Getzmann & Näätänen, 2015) are impaired
by aging. Auditory temporal processing is impacted by PD (Guehl et al., 2008).
Dopaminergic therapy has been found to worsen auditory distractor processing in PD
(Georgiev et al., 2015). Effects of PD and dopaminergic therapy on pattern and
association learning are somewhat complex. The vast majority of studies, however, find
that at baseline PD patients perform sequence (Kwak et al., 2010) and association learning
normally relative to age-matched controls (De Wit, Barker, Dickinson, & Cools, 2011;
Sharp, Foerde, Daw, & Shohamy, 2016) and this normal performance is actually
worsened by dopaminergic therapy (Cools, 2006, 2001; Cools et al., 2007a, 2003; Feigin
et al., 2003; Graef et al., 2010; Hiebert et al., 2019, 2014a; Jahanshahi et al., 2010; LevyGigi et al., 2019; MacDonald et al., 2013, 2011; Seo et al., 2010; Shohamy et al., 2006,
2005; Swainson et al., 2000; Tomer et al., 2007; Torta et al., 2009; Tremblay et al., 2010;
Vo et al., 2014; for reviews see Cools, 2006; Macdonald and Monchi, 2011).
Dopaminergic therapy also worsens association learning in healthy elderly (Vo et al.,
2018; Breitenstein et al., 2006; Mehta et al., 2001; Santesso et al., 2009), and younger
(Hiebert, Vo, et al., 2014; Vo, Seergobin, & MacDonald, 2017a; Vo, Seergobin, Morrow,
& MacDonald, 2016) controls. These detrimental effects of dopaminergic therapy are
ascribed to overdose by exogenous dopamine of brain regions that are VTA-innervated
and hence relatively dopamine replete (Cools, 2006). Consequently, this study will have
the potential to uncover how aging, PD, and exogenous dopamine might impact the neural
response associated with regularity processing. Regularity processing has been
investigated minimally in healthy aging (Herrmann et al., 2019b), and to this point, it has
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not been examined in PD or in relation to exogenous dopamine at all. Consequently, this
research fills an important knowledge gap.
The aim of this study was to investigate the effect of aging, PD, and exogenous dopamine
(e.g., L-dopa) on regularity processing. We measured EEG-evoked responses for elderly
controls and PD patients while they listened to tone sequences that either contained a
regular auditory pattern or were entirely random. Healthy elderly control participants and
PD patients performed this EEG-auditory processing task both off and on exogenous
dopamine therapy. Previously-collected data of healthy younger controls in a protocol
identical to the one administered here in the OFF dopaminergic therapy state only
(Herrmann & Johnsrude, 2018b), were compared to our data, presuming that neural
responses to regularity in healthy young undergraduates represented optimal responses. If
aging impacts regularity processing in auditory scene analysis, we expect EEG signal
differences in our healthy elderly controls compared to healthy younger participants in the
OFF state. Moreover, if regularity processing depends upon DS and/or DS’s cortical
partners, regularity processing is expected to be a) impaired in PD patients at baseline, in
the OFF state, relative to age-matched controls, and b) improved and even potentially
normalized in PD patients tested in the ON state, relative to elderly control participants’
performance. In contrast, if regularity processing depends upon VTA-innervated brain
regions such as VS limbic, or prefrontal cortices, regularity processing is predicted to be
comparable in early and mid stage PD patients and elderly controls off dopaminergic
therapy. This is because VTA is relatively spared until later in PD. Further, regularity
processing is expected to worsen following administration of dopamine in both healthy
elderly and PD, due to the previously-demonstrated phenomenon of dopamine overdose
of VTA innervated brain regions in both healthy controls (Vo et al., 2018; Breitenstein et
al., 2006; Mehta et al., 2001; Santesso et al., 2009) and PD patients (Cools, 2006, 2001;
Cools et al., 2007a, 2003; Feigin et al., 2003; Graef et al., 2010; Hiebert et al., 2019,
2014a; Jahanshahi et al., 2010; MacDonald et al., 2013, 2011; Robertson et al., 2018; Seo
et al., 2010; Shohamy et al., 2006, 2005; for reviews see Cools, 2006; Macdonald and
Monchi, 2011).
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Materials and methods
2.2.1

Participants

Nineteen PD patients, (7 females; SEM = 66.5±6.1 years), 19 age- and education-matched
healthy controls (aCT; 12 females, 65.7±6.7 years) were recruited for this study. Data
from one PD patient was excluded due to the use of a hearing aid and data from two
healthy controls were excluded because they did not complete both sessions. Health and
demographic information for aCT and PD patients are presented in Table 2.1. Data from
16 healthy young controls (yCT; 10 females, 18.4 ± 0.9 years) collected in a previous
study using an identical procedure (Herrmann & Johnsrude, 2018b) were included in our
OFF-state analyses.
All participants with PD were previously diagnosed by a licensed neurologist, had no
co-existing diagnosis of dementia, or another neurological or psychiatric disease, and met
the core assessment for surgical interventional therapy and the UK Brain Bank criteria for
the diagnosis of idiopathic PD (Hughes, Daniel, Kilford, & Lees, 1992). All PD patients
were treated with regular dopaminergic therapy. ACT were within five years of age
(average difference was 3.6 years) and three years of education (average difference was
2.4 years) of their matched PD patient (p = 0.653 and p = 0.342, respectively). No
controls were treated with any dopamine-modulating therapy. Participants with PD were
recruited through the Movement Disorders Database at the London Health Sciences
Centre, Ontario, Canada. Participants abusing alcohol, prescription or illicit drugs, or
taking cognitive-enhancing medications including donepezil, galantamine, rivastigmine,
memantine, or methylpheniate, or who presented any hearing impairment were excluded
from participating in this study.
The motor sub-scale of the Unified Parkinson’s Disease Rating Scale (UPDRS) was
scored by a licensed neurologist with sub-specialty training in movement disorders
(P.A.M.) to assess the presence and severity of motor symptoms for all patients both off
and on dopaminergic medication. ACT were also screened with UPDRS motor sub-score
to rule out undiagnosed neurological illness. Mean group demographic, as well as
cognitive and affective screening scores for all patients and controls in each experimental
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group are presented in Table 2.1. UPDRS motor subscale scores off and on dopaminergic
therapy, daily doses of dopamine replacement therapy in terms of L-dopa equivalents
(LED), and mean duration of PD were also recorded and presented in Table 2.1.
Calculation of daily LED for each patient was based on the theoretical equivalence to Ldopa(mg) as follows: L-dopa dose(mg) × 1 + L-dopa controlled release(mg) × 0.75 + Ldopa(mg) × 0.33 if on entacapone(mg) + amantadine(mg) × 0.5 + bromocriptine(mg) × 10
+ cabergoline(mg) × 50 + pergolide(mg) × 100 + pramipexole(mg) × 67 + rasagiline(mg)
× 100 + ropinirole(mg) × 16.67 + selegiline(mg) × 10 (Wullner et al., 2010).

Table 2.1: Demographic, Clinical, Cognitive, And Affective Measures In aCT And PD Patients
aCT

PD

p value

N

18

18

Age

66.89 (6.25)

65.94 (5.72)

Disease Duration

N/A

6.78 (4.89)

L-dopa

N/A

511.39 (299.15)

MOCA

28.33 (1.60)

27.61 (1.81)

0.21

ANART

124.40 (8.55)

123.80 (5.48)

0.8

Oxford happiness scale

4.00 (1.627)

3.42 (0.68)

0.22

OFF

1.94 (2.58)

10.27 (5.49)

<0.01*

ON

1.61 (2.06)

8.00 (4.91)

<0.01*

OFF

4.44 (4.40)

10.11 (5.81)

<0.01*

ON

4.61 (4.27)

10.50 (6.51)

<0.01*

OFF

9.38 (4.43)

12.00 (5.89)

0.12

0.64

BAI

BDI-II

Apathy
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ON

8.88 (3.61)

13.17 (6.53)

0.02*

OFF

1.18 (0.42)

26.91 (1.22)

0.168

ON

0.96 (0.31)

22.26 (1.19)

<0.01*

UPDRS

Data are presented as mean (SEM). MOCA: Montreal Cognitive Assessment; ANART: National Adult
Reading Test; BAI: Beck Anxiety Inventory; BDI-II: Beck Depression Inventory-II; Apathy: Starkstein
Apathy Scale. UPDRS: Unified Parkinson’s Disease Rating Scale. aCT = age matched healthy Controls, PD
= Parkinson’s disease patients

All participants provided written informed consent to the protocol before beginning the
experiment. The study was conducted in accordance with the Declaration of Helsinki
(World Medical Association, 2013). This study was approved by the Health Sciences
Research Ethics Board of the University of Western Ontario.

2.2.2

Protocol

ACT and PD patients were recruited for two recording sessions, conducted at the Brain
and Mind Institute at the University of Western Ontario. During the OFF session, PD
patients were instructed to abstain from taking their dopaminergic medication as follows:
L-dopa/carbidopa and entacapone were withheld for 12-18 hours and dopamine agonists
such as pramipexole, ropinirole, or pergolide, as well as amantadine, rasagiline, and
selegiline were not taken for 16–24 hours before testing. Healthy controls took a placebo
consisting of cornstarch in the OFF state. During the ON Session, patients were instructed
to take their medications as prescribed by their treating neurologist. In the ON Session,
healthy controls took 100 mg of L-dopa and 25 mg of carbidopa at the beginning of the
session, followed by a waiting period of 45 minutes to maximize medication absorption
and peak plasma dopamine levels for experimental testing. Placebo and L-dopa were
given to aCT in identical capsules prepared by a lab member who was not involved in the
study to ensure blinding of both the participant and the experimenter. The OFF and ON
sessions were counterbalanced across all participants. The OFF-ON order of the aCT
corresponded to the OFF-ON order of the PD patient to whom s/he was matched. ACT
were instructed to abstain from consuming heavy meals, alcohol, and/or caffeine the night
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before and the morning of each session, so there was minimal interference with dopamine
absorption. Patients and healthy elderly controls completed questionnaires assessing
anxiety, depression, and apathy.
Cognitive function was also assessed using the Montreal cognitive assessment (MoCA),
and the American National Adult Reading Test (ANART). At the end of the waiting
period (45 minutes) during both sessions, all participants performed the UPDRS Motor
Sub-scale. At the beginning of each session, a participant’s hearing ability threshold was
estimated for each ear using pure-tone audiometry (Fig. 2.1). YCT were not tested on
dopamine treatment, as the data were collected in a previous study (Herrmann &
Johnsrude, 2018b). YCT participants self-reported normal-hearing abilities but these were
not explicitly tested given the low likelihood of hearing impairment at the young mean
age of this group.

Figure 2.1: Audiometric Data for aCT And PD Patients OFF and ON Medication.
(A) Mean audiograms for aCT patients OFF (dotted red line) and ON (solid blue line) are presented,
collapsed across left and right ears. (B) Mean audiograms for PD patients OFF (dotted red line) and ON
(solid blue line) medication are presented, collapsed across left and right ears. There were no significant
differences between groups or related to dopaminergic therapy in the hearing threshold across the frequencies
of our tone stimuli in this study. Error bars represent standard error about the mean (SEM).

2.2.3

Acoustic stimulation:

Participants watched a muted movie with subtitles while they were passively presented
with sounds via Sennheiser HD25SP II headphones and a Steinberg UR22 (Steinberg

44

Media Technologies) external sound card. Stimulus presentation was controlled by a PC
(Windows 7, 64 bit) running Psychtoolbox in MATLAB (R2015b).
Acoustic stimuli were similar to those used in previous studies (Barascud et al., 2016b;
Herrmann & Johnsrude, 2018b; Southwell, Baumann, Gal, Barascud, & Friston, 2017).
Stimuli were 4-s-long sequences made of 0.04-s tones (0.007 s rise time; 0.007 s fall time;
100 tones per sound; no gap between tones). Each stimulus sequence comprised 10 sets of
tones and each set was 10 tones (0.4 seconds) long. The frequency of a tone could take on
one of 70 values ranging from 700 to 2500 Hz (logarithmically spaced).
The selection of frequency values for each of the 10 sets depended on the stimulus
condition. Two conditions were created. For the random condition (RAND), containing
no regularity, 10 new frequency values were randomly selected for each of the 10 sets
(Fig. 2.2, Panel A). In the regular condition (REG), 10 new frequency values were
randomly selected for each of the first 4 sets (0–1.6 seconds identical to RAND
condition), and then 10 new random frequency values were selected and repeated for set 5
through10, thereby creating a regularity. That is, the serial order of tone frequencies was
identical in the repeating sets between 5 and 10 (Fig. 2.2, Panel B). In this way, in the
REG condition, the tones transformed from a random to a regular sequence of tones.
Selection of these 10 frequency values and their serial order, used to create the regularity,
differed from trial to trial. Each stimulus was presented 108 times over the duration of 3
blocks and individual stimuli were separated by an inter-stimulus interval of 1.5 s. Trials
for each condition were presented in a randomized fashion within each block. Stimuli
from the RAND and REG conditions were presented along with other auditory stimuli
that will not be discussed here.

2.2.4

EEG recording

Participants were instructed to remove any electronic devices, watches, or hair clips,
before each recording session. EEG signals were recorded at a sampling rate of 1024 Hz
using 16 Ag/Ag-Cl electrodes (Fp1, Fp2, F3, Fz, F4, C3, Cz, C4, T7, T8, P3, Pz, P4, O1,
Oz, O2) and left and right mastoid electrodes (Bio-Semi; 208 Hz low-pass filter).
Electrodes were referenced to a monopolar reference feedback loop, connecting a driven
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passive sensor and a common-mode-sense (CMS) active sensor, both located posterior on
the scalp. The experiment was conducted in a sound-attenuated booth.
Figure 2.2: Stimulus Structure For Random
(RAND) And Regular (REG) Stimuli:
Stimulus conditions and examples of tone
presentation in each condition. Examples of
auditory stimuli in the Random (RAND) and
Regular (REG) conditions are presented in Panel A
in red and Panel B in blue, respectively. Each
stimulus consisted of ten sets of tones. Each set
contained ten tones with a duration of 40 ms/tone.
A) For the RAND condition, the tone frequencies
for each set were drawn randomly from a pool that
ranged from 700 to 2500 Hz. B) For the REG
condition, tone frequencies for each set were drawn
randomly for the first 4 cycles (1.6 sec). For the
remaining sets, 10 tone frequencies were randomly
selected and repeated from cycles 5 through 10 (1.64 sec). In other words, the REG stimulus
transitioned from random to regular, indicated by a
vertical dotted line in Panel B.

2.2.5

EEG data analysis of the sustained response

Offline data analysis was carried out using MATLAB software (8.6; MathWorks, Inc.).
An elliptic filter was utilized to remove line noise (60 Hz) from the raw data. Offline
filtering of the raw data consisted of high-pass filtering at a cutoff of 0.7 Hz (2449 points,
Hann window) and low-pass filtering at 22 Hz (211 points, Kaiser window). Data was
then down sampled to 512 Hz and re-referenced to the averaged mastoid electrodes. Data
was subdivided into five second epochs time-locked to sound onset (-0.8 to 4.8 sec).
Independent components analysis (runica method: Makeig, J. Bell., Jung, & Sejnowski,
1996 ; logistic infomax algorithm: Bell & Sejnowski, 1995; Fieldtrip implementation:
Oostenveld, Fries, Maris, & Schoffelen, 2011; RRID:SCR_004849) was employed to
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identify components related to blinks and horizontal eye movements. The sustained
response was investigated using the low-pass filtered data only, meaning that high-pass
filtering was omitted in order to retain the low-frequency signal that is reflective of a DC
shift and representative of the sustained response (Barascud et al., 2016b; Herrmann &
Johnsrude, 2018b; Winkler et al., 2009). However, components from the high-pass
filtered data were used to remove activity related to blinks and horizontal eye movements.
Epochs that exceeded a signal change of 200 µV in any electrode were excluded from
analyses.
Analyses focused on neural activity time-locked to the transition to the regular pattern
(1.6 s). Single trials were averaged for both conditions (RAND and REG). To baseline
correct the response time course, we subtracted the mean amplitude in the pre-regularity
interval (-0.8 to 0 seconds, time-locked to the transition to the regular pattern for the REG
condition and to the corresponding time point in the RAND condition) from the amplitude
at each time point; this was done for each electrode separately. Sustained response data
were calculated by averaging signals across the fronto-central-parietal electrode cluster
(Fz, F3, F4, Cz, C3, C4, Pz, P3, P4) and calculating the mean amplitude for each
condition (RAND and REG) for the 0.8 to 2.4 s time window, that is, the time window in
which regularity processing is expected to be completed (Barascud et al., 2016b).
Selection of the fronto-central-parietal electrode cluster was motivated by previous work
on regularity processing showing spatially wide-spread sustained response that is also
consistent with the localization of the sustained responses in the auditory cortex and
higher-level brain areas (Barascud et al., 2016; Herrmann et al., 2019b).
Next, we calculated the amplitude difference of the sustained response between random
and regular (REG-minus-RAND). We calculated the mean amplitude of the sustained
response for 4 cycles of regularity, that is cycles 2 to 6 after regularity emergence (0.8 to
2.4 seconds). Previous studies have indicated that the sustained response amplitude is
larger (i.e., more negative in EEG) during the REG compared to the RAND conditions
(Barascud et al., 2016b; Herrmann & Johnsrude, 2018b; Southwell, Baumann, Gal,
Barascud, & Friston, 2017).
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2.2.6

Statistical analysis

We compared the REG-minus-RAND sustained response difference for yCT, aCT, and
PD, in the OFF state, in a one-way analysis of variance (ANOVA) using both frequentist
and Bayesian approaches. This was followed by Tukey post-hoc multiple comparisons, to
test differences between each of the three groups again using frequentist and Bayesian
approaches. Finally, we compared the amplitude of the REG-minus-RAND sustained
response difference for each group (yCT, aCT, and PD) against zero, using frequentist and
Bayesian one sample t-tests.
We next performed an analogous set of analyses on the REG-minus-RAND sustained
response difference in the ON Session. Only aCT and PD groups performed regularity
processing on dopaminergic therapy. First, we compared aCT and PD in a one-way
ANOVA using frequentist and Bayesian approaches. Next, we compared the amplitude of
the REG-minus-RAND sustained response difference for each group (aCT and PD)
against zero using a) a frequentist one-sample t-test, and b) a Bayesian approach.
For frequentist analyses in this study, we set our criteria for significance at α < 0.05. For
our Bayesian analyses, a Bayes factor (BF10) less than one strongly supports the null
hypothesis. When BF10 is between one and three, this provides anecdotal support for the
alternative hypothesis, and when it is greater than three, this represents moderately to
extremely strong support for the alternative hypothesis, scaling up with the value of BF10.
A Bayes factor of three has previously been shown to be the Bayesian corollary of p <
0.05 in frequentist hypothesis testing (Dienes, 2014).
The frequentist approach to statistical analyses is more common and familiar. However,
this approach places the null and alternative hypotheses on unequal footings. Type I and
Type II errors are usually set at 0.05 and 0.20 respectively. This means that rejecting the
null hypothesis and accepting the alternative hypothesis occurs in error, by chance alone,
5% of the time (i.e., 1/20 times) using frequentist approaches. By contrast, failing to reject
the null hypothesis occurs in error, by chance alone, 20% of the time (i.e., 1/5 times).
Given this high error probability, frequentist approaches are not favoured for assessing the
null hypothesis. Here, given the a priori potential that healthy elderly controls and PD
patients would have comparable performance, and hence that we would need to evaluate
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data that would fail to reject the null hypothesis, we chose to present, in addition to the
more familiar frequentist analyses, corresponding Bayesian analyses. Bayesian analyses
allow direct contrasts of the probability of the null and the alternative hypotheses, putting
these hypotheses on an equal footing with equivalent error levels, and enable direct
comparisons of the relative fit of the two models to the data. Bayesian analyses provide
probabilistic estimates of the veracity of our null hypotheses (Dienes, 2014) allowing us
to draw conclusions about our data.

2.2.7

Disease specific correlation

Regularity detection could be affected by stage of disease or other clinical variables. To
investigate this possibility, we correlated disease stage using years since diagnosis and
LED with regularity processing. LED reflects the daily dose of dopamine replacement
therapy. It is expected that with disease progression, symptoms will worsen and thus
exogenous dopamine doses will increase. In this way, LED is considered a measure of
disease progression and severity. Further, regularity processing could also be affected by
cognitive function. We further correlated MoCA scores with the neural sustained response
(i.e., REG-minus-RAND). It should be noted that we sought to test only cognitively intact
participants by using: MoCA, participants symptoms, and neurologist opinion to include
or exclude patients. Moreover, we wanted to rule out the effect of anxiety and depression
measures on the neural sustained response. We performed correlation between the
sustained response (REG-minus-RAND) and anxiety and depression measures (i.e., BAI
and BDI-II, respectively). In all cases, we used Pearson correlation. Statistical analyses
were conducted via MATLAB software (8.6; MathWorks, Inc.) and JASP Team [2019;
JASP (Version 0.11.1) Computer software].

Results
2.3.1

Demographic and clinical data.

Health and demographic information for both aCT and PD patients are presented in Table
2.1. The disease duration ranged from 1 to 17 years, with a mean [±standard error about
the mean (SEM)] duration of 6.78 (± 4.89) years since diagnosis. ACT and PD patients
performed similarly on ANART (t34= -0.24; p = 0.80), MoCA (t34= 1.26; p = 0.21), and
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Oxford happiness scale (t34= 1.34; p = 0.18). ACT scored lower than PD patients on the
BAI and BDI-II indicating lower levels of anxiety and depression, regardless of the
medication state, as has been shown previously shown ( MacDonald, Monchi, et al., 2013;
MacDonald & Monchi, 2011; Vo et al., 2014). ACT scored lower than PD patients on our
measure of apathy when they were tested on dopaminergic therapy but there were no
group differences in apathy scores in the OFF state. There were no OFF-ON differences
for our cognitive/affective measures in either group. Finally, as expected, aCT scored
significantly lower than PD patients on the UPDRS Motor sub-scale (t34 = 20.01 = p <
0.001). Performance on UPDRS Motor sub-scale improved with dopaminergic therapy for
PD patients (t17 = 6.67, = p < 0.001).
The mean age of our yCT group was 18.6 (SEM = 0.5, 8 females). The health,
demographic, and cognitive measures described above were not collected for the yCT
group.
3.2. Sustained response in YCT, ACT, and PD patients OFF medication
Neural sustained response for both conditions are represented for each group (Fig. 2.3).
We tested the effect of Group on the sustained response difference between REG-minusRAND conditions in the OFF Session in a one-way frequentist ANOVA and a Bayesian
ANOVA. We found a highly significant main effect of group using both approaches (F2,49
= 6.533, ƞp2 = 0.211, p = 0.003; BF10 = 13.203). Pairwise comparisons, using independent
samples t-tests and Bayesian independent samples t-test, revealed that the difference in
REG-minus-RAND for yCT was significantly larger than for aCT (t32 = 3.167; p = 0.003;
BF10 = 11.681). This provided strong support for the difference between yCT and aCT. In
addition, the contrast of neural responses for yCT and PD patients revealed a significant
difference with larger amplitude difference for REG-minus-RAND in yCT compared to
PD groups (t32 = 2.327; p = 0.026). The Bayes Factor revealed anecdotal strength evidence
for the yCT-PD difference (BF10 = 2.448). In contrast, there was no significant difference
between the sustained responses of REG-minus-RAND between aCT and PD patients (t34
= 1.454; p = 0.155; BF10 = 0.727), with the Bayes Factor strongly supporting the null
hypothesis.
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One sample t-tests on the divergence between regular and random auditory sequences
(REG-minus-RAND), referred to as the sustained response, revealed significant
differences for all groups, yCT, aCT, and PD, in the OFF dopaminergic medication
condition (Table 2.2). This was fully supported by Bayesian one sample t-tests as well
(Table 2.2). Significant differences in one sample t-tests indicate that the discrepancy in
REG-minus-RAND condition is not statistically equal to zero for all three groups off
medication. This indicates sensitivity of neural activity to temporal regularity in sounds
(Herrmann and Johnsrude, 2018).
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Figure 2.3: Time Course For The Sustained Response For Random (RAND) and regular (REG)
Sequences:
Panel A presents the neural sustained response time course for REG versus RAND from 0.8 seconds
prior to the emergence of regularity up to 2.4 seconds following the emergence of regularity in yCT,
aCT, and PD in the OFF Session on the Left and in aCT and PD in the ON Session on the Right. REG
neural response time courses are presented in dotted lines whereas RAND neural response time
courses are presented in solid lines. Panel B presents the mean of the sustained response during the
analysis window, which is 0.8 to 2.4 seconds following regularity, for yCT, aCT, and PD in the OFF
Session on the Left and for aCT and PD in the ON Session on the Right. The neural sustained
response for REG-minus-RAND was attenuated in aCT and PD groups in the OFF Session. Further
attenuation was observed for the REG-minus-RAND neural sustained response for aCT and PD
groups in the ON Session. Error bars represent the standard error of the mean (SEM).

Figure 2.4: Sustained Response Difference (REM-minus-RAND) In yCT, aCT, and PD:
Bayesian ANOVA on the neural sustained response difference, REG-minus-RAND for yCT, aCT, and
PD off dopaminergic medication (Left), and aCT and PD patients on dopaminergic medication (Right)
are presented. Off medication (Left), yCT display a larger sustained response (i.e., REG-minus-RAND
EEG amplitude difference) compared to aCT and PD patients. On medication (Right), both aCT and PD
patients displayed no significant sustained neural response difference for REG-Minus-RAND.
yCT = Young healthy Controls, aCT = Aged healthy Controls, PD = patients with Parkinson’s disease.
*p=0.05, ** p<0.01, NS = Not significant. Error bars represent the standard error of the mean (SEM).
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2.3.2

Sustained response in ACT and PD patients ON medication

YCT participants did not perform the task on L-dopa. For this reason, investigations in the
ON state were carried out using data only from aCT and PD patients. One-way frequentist
and Bayesian ANOVAs on neural sustained response (i.e., REG-minus-RAND) from aCT
compared to PD groups revealed no main effect of group (F1,34 = 0.29, ƞp2 = 0.001, p =
0.873; BF10 = 0.325). The Bayes Factor again strongly supported the null hypothesis.
Further, one sample t-tests did not reach significance with respect to the difference
between REG and RAND for both aCT and PD in the ON Session (Table 2.2). That is, the
amplitude difference of REG-minus-RAND for both groups, aCT and PD, in the ON
Session were not significantly different from zero. The Bayes Factor provided only
anecdotal level evidence in support of the null hypothesis. Unlike in the OFF state, there
was not convincing evidence of a sustained response which indicates regularity detection,
in aCT and PD groups in the ON state (Table 2.2).

2.3.3

Disease specific correlation

To investigate the effect of disease stage, severity, and cognitive function, we correlated
the years since diagnosis (i.e., disease stage), LED, and MoCA scores with REG-minusRAND off and on medication. We did not find any significant correlations for the REGminus-RAND amplitude with any of our clinical and cognitive variables in the OFF (r =
0.206, p = 0.412; r = -0.194, p = 0.441; and r = -0.206 p = 0.411, respectively) or in the
ON (r = 0.105, p = 0.679; r = 0.029. p = 0.909; and r = -0.242, p = 0.334, respectively)
states. In addition, there were no significant correlations between the sustained response
for REG-minus-RAND and anxiety and depression measures (BAI and BDI-II,
respectively) either off or on medication (Table 2.3).

Discussion
2.4.1

Summary of Results

In this study, we found that a regular pattern in sounds elicited a sustained neural response
in all groups but was significantly attenuated for aCTs and PD patients relative to the
response in yCTs. There were no differences in the amplitude of the sustained response
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Table 2.2: One Sample t-tests To Compare Sustained Response Difference
Comparing the difference in neural sustained response between REG and RAND (REG-minus-RAND) for
all groups (yCT, aCT, PD) off and on medication, relative to zero.
One Sample T-Test and Bayesian One Sample T-Test
t

df

p

BF₁₀

yCT off medication *

-5.454

15

< .001

408.795

aCT off medication *

-2.444

17

0.026

2.441

PD off medication *

-5.729

17

< .001

984.685

aCT on medication

1.330

17

0.201

0.518

PD on medication

-1.867

17

0.079

1.014

Note. Student's t-test. df = degrees of freedom; BF10 = Bayes Factor. yCT = Younger controls; aCT = Age
matched controls; PD = patients with Parkinson’s disease.
* Significant difference

Table 2.3: Correlation Between Sustained Response and Anxiety and Depression
Pearson correlation between REG-minus-RAND amplitude and Anxiety and Depression scores
(BAI and BDI-II, respectively) for healthy elderly controls and PD patients off and on
medication.

On Medication

Off Medication

aCT

PD

Pearson's
r

p

Pearson's
r

p

BAI_Off

0.081

0.748

-0.012

0.962

BAI_On

-0.008

0.974

-0.086

0.736

BDI-II_Off

-0.217

0.387

-0.039

0.879

BDI-II_On

-0.279

0.263

-0.187

0.458

BAI_Off

0.23

0.359

-0.163

0.518

BAI_On

0.159

0.527

-0.093

0.714

BDI-II_Off

0.019

0.94

0.02

0.938

BDI-II_On

0.019

0.941

-0.062

0.808

REG-minus-RAND

REG-minus-RAND

BAI: Beck Anxiety Inventory; BDI-II: Beck Depression Inventory-II
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for REG-minus-RAND between aCTs and PD patients. This suggests that sensitivity to
regularity reduces with aging but the pathophysiological processes that produce PD do not
adversely impact this sensitivity beyond the effects of aging. These findings suggest that
aging, but not PD per se, affect auditory regularity processing. Furthermore, we found
that the neural signature of regularity detection was not significant for healthy elderly
controls and PD patients when they were tested on dopaminergic therapy. This is
consistent with dopamine overdose. Exogenous dopamine was not administered to the
yCT group. Disease duration, LED, and cognitive abilities (i.e., MoCA scores) did not
correlate with REG-minus-RAND amplitudes in PD patients, neither when they were off
nor when they were on medication. Finally, anxiety and depression measures did not
significantly correlate with the sustained response for REG-minus-RAND for both aCT
and PD patients, in both the OFF and ON sessions.

2.4.2

Regularity Processing in Aging

The observation that regularity-related sustained activity is reduced in older compared to
younger adults is in line with recent work showing a similar trend for amplitudemodulated sounds (Herrmann et al., 2019b). This finding is in line with a number of
results in healthy elderly participants in auditory processing, particularly related to
temporal processing and parsing of stimuli. Aging has been previously found to reduce
the ability to properly segregate temporally-adjacent auditory stimuli (Aghamolaei et al.,
2018; Rimmele, Sussman, & Poeppel, 2015c; Stothart & Kazanina, 2016). To analyze
busy auditory environments, it is necessary to detect the emergence or onset of regular
patterns that often signal novel stimuli. Studies investigating auditory scene analysis in
older adults have also proposed an impairment in stream segregation, which could be
attributed to auditory sensory memory deficits (Rimmele et al., 2015c; Rimmele,
Schröger, & Bendixen, 2012b), selective attention towards stimuli (Aghamolaei et al.,
2018; Alain et al., 1996; Christiansen, 2014; Dinces & Sussman, 2017), improper
inhibitory processes of irrelevant sounds (Snyder & Alain, 2007; Stothart & Kazanina,
2016). It has been suggested that older adults have deficits in sequential grouping and are
less able to capitalize on certain regularities for better stream segregation (J. Rimmele,
Schröger, et al., 2012b). Getzsmann and Näätänen (2015) found that older adults have

55

deficiencies in stream segregation potentially because they require more time to properly
isolate competing auditory inputs when speech in noise was investigated, with the
expectation that noise would obscure parts of the conversation, making it harder to follow
(Getzmann & Näätänen, 2015). These deficits in aspects of the auditory scene analysis
associated with aging seem related to impairments in detecting patterns and segregating
them from random or irrelevant auditory stimuli. Despite these previous studies that hint
at a problem in regularity processing and detection, ours is one of the few studies to
explicitly investigate this and to show that indeed, the neural response related to
presentation of a regular pattern embedded in random auditory stimuli is attenuated in
healthy elderly participants relative to young controls (Herrmann et al., 2019b). Our
finding sheds light on these previous auditory processing deficits that have been noted
with aging.

2.4.3

Regularity Processing in PD

No previous studies have investigated the effect of PD on regularity processing using a
paradigm similar to ours. PD is a neurodegenerative disorder with prominent motor
dysfunction that is related to the loss of dopamine-producing neurons, particularly in the
SNc. We found that PD patients and elderly, healthy, age-matched controls experienced
similar attenuation of the sustained response, assessed with EEG, relative to young
controls. Regularity processing seems spared by PD pathophysiological processes in that
PD did not worsen the neural response related to regularity processing beyond the main
effect of aging. Healthy older controls and patients with PD have shown similar distractor
processing in the auditory stream using an oddball task, which is suggested to depend
upon regularity processing (Georgiev et al., 2015). Moreover, PD patients, only tested on
medication, have shown deficiencies in neural entrainment, with an associated deficit
between auditory to motor entrainment (Te Woerd et al., 2017, 2015; Te Woerd et al.,
2017). Few studies have systematically sought to disentangle the effects of PD versus
dopaminergic therapy on auditory processing through direct contrasts of performance off
and on dopaminergic therapy as we have done in this study. Consequently, in a number of
studies in this small literature investigating auditory processes that incorporate regularity
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processing, clear conclusions regarding the effects of PD, independent of the effect of
dopaminergic therapy, can be drawn.
Here, we implemented a protocol aimed at investigating automatic regularity processing
using EEG and excluding an explicit response. In aging (Dinces & Sussman, 2017) and
neurodegenerative diseases such as PD (Heldmann, Teichmann, Al-Khaled, Brüggemann,
& Münte, 2019), deficits in automatic processing occur. The current protocol has an
advantage given that our study sought to evaluate regularity processing in a patient group
with clear motor planning, movement initiation, and motion execution deficits (Martin et
al., 2019; Plotnik, Flash, Inzelberg, Schechtman, & Korczyn, 1998). This protocol
obviates the need for manual responses and circumvents effects of PD-related motor
delays. In this way, we could assess auditory regularity detection in PD directly. Based on
the work of Barascud and colleagues (2016), the EEG sustained response corresponds
with explicit regularity detection signaled by overt responses. Given this previous
validation, here we interpret that regularity processing is impaired as a result of aging but
is not further worsened by moderate PD. Regularity detection underlies many cognitive
processes. Understanding how regularity processing is affected by aging and PD adds to
the growing literature regarding cognitive deficits associated with these conditions. Future
studies should seek to explicitly link regularity processing deficits and impairment in
cognitive processes that depend upon regularity detection (e.g., speech processing,
association learning) in aging and PD.

2.4.4

Effect of Dopaminergic Therapy on Regularity Processing

Additionally, we investigated the effect of dopaminergic therapy on regularity processing
in both our healthy elderly controls and in PD patients. We found that when healthy
elderly and PD participants were tested on dopaminergic therapy, the sustained response
was attenuated to the point that there were no significant differences in the EEG responses
for sequences in the regular compared to random conditions (REG-minus-RAND).
Georgiev and colleagues (2015) found that dopaminergic therapy significantly worsened
distractor processing in an auditory oddball paradigm that depends upon regularity
detection and processing to perform this task. Our effects and those of Georgiev and
colleagues are in line with the dopamine overdose hypothesis (Cools, 2006; P. A.
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MacDonald & Monchi, 2011). This hypothesis proposes that the effect of exogeneous
dopaminergic therapy on functions are determined by the level of endogenous dopamine
in the brain regions that underlie them. In PD, SNc is significantly degenerated and the
DS, which it supplies, is substantially dopamine depleted. As a consequence, functions
mediated by DS, such as motor functions, reliably improve with dopaminergic therapy
(Birkmayer & Hornykiewicz, 1961; Cotzias et al., 1969; Hiebert et al., 2019; P. A.
MacDonald & Monchi, 2011). In contrast, the VTA is relatively spared in PD, and
exogenous dopamine distributes to regions that are VTA-innervated. This overdoses these
brain regions, which include the VS and the limbic and prefrontal cortices, impairing their
functions.
This attenuation of the sustained response with dopaminergic therapy is predicted given
that the few studies which have investigated the brain regions that mediate regularity
processing using MEG and fMRI (Barascud et al., 2016b; Sohoglu & Chait, 2016;
Southwell, Baumann, Gal, Barascud, & Friston, 2017; Teki et al., 2016) have found a
relation between regularity processing and activation in hippocampus and inferior frontal
gyrus (IFG). These are VTA-innervated brain regions. Our results support the contention
that regularity processing depends upon one or more VTA-innervated brain region. These
findings are therefore complementary to findings in the very limited, existing literature
that has investigated the neural mechanisms underlying regularity processing.

2.4.5

Effect of Clinical Variables on Regularity Processing

PD stage or severity could impact regularity processing. Further, PD stage could promote
differential effects of exogenous dopamine on regularity processing. These effects might
occur due to the progressive degeneration of VTA at later stages of PD. The small
literature on neural regions that mediate regularity processing and our own findings here
suggest that a VTA-innervated brain region underlies regularity detection and processing.
This could cause baseline deficits in regularity detection relative to age-matched controls
for late-stage PD patients, as well as dopaminergic therapy-related improvements rather
than impairments in regularity detection at more advanced stages of PD. Though this is
speculative, there are indices (Cools et al., 2007; MacDonald et al., 2013a Cools, 2006;
Cools and D’Esposito, 2011; Macdonald and Monchi, 2011) that early and late PD
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patients evidence differences in cognition and behaviour, and that dopaminergic therapy
affects these processes differently at early versus late stages of PD. In the current study,
our PD patients had an average of 6.88 years since diagnosis, and hence were on average
at moderate stages of disease. On the whole, we saw no group difference in regularity
detection, beyond the effect of normal aging, in the PD group relative to age-matched
controls. The effect of dopaminergic therapy was equally detrimental to the sustained
response in PD patients and age-matched controls—a pattern consistent with functions
performed by VTA-innervated brain regions that are relatively spared in PD. Furthermore,
we investigated the effect of disease progression, severity, and cognition on regularity
detection, correlating years since PD diagnosis (i.e., disease stage), LED, and MoCA
scores with REG-minus-RAND off and on medication. We did not find any significant
correlations for the REG-minus-RAND amplitude with any of these variables. Future
investigations should include later-staged PD patients to understand the full impact of PD
and dopaminergic therapy on regularity processing in this disease.
We also investigated the effect of anxiety and depression on regularity processing in PD
patients and healthy elderly controls and found no significant correlation between the
magnitude of the sustained response (i.e., REG-minus-RAND) and the level of anxiety
and depression measured using the BAI and BDI-II questionnaires. This is not unexpected
given the fact that anxiety affects attentional control (Eysenck et al., 2007), which should
not impact regularity processing—a presumed automatic process. In contrast, depression
has been shown to affect early auditory processing (Kähkönen et al., 2007) though we did
not find any correlation between the REG-minus-RAND sustained response and
symptoms of depression measured with the BDI-II. However, it is worth mentioning that
the anxiety and depression levels measured in this study did not exceed the cutoffs for
moderate generalized anxiety or depression. Regularity processing has not been
investigated in the context of anxiety or depression as a primary aim. Future studies
investigating the effect of these prevalent mood and affective disorders on regularity
detection and processing will be important.
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2.4.6

Regularity Processing and Cognitive Functions in Aging and
PD

We have found that aging and dopaminergic therapy, but not PD, worsen regularity
detection, a fundamental process that potentially underlies many cognitive functions
(Chennu et al., 2013; Summerfield & De Lange, 2014). Regularity processing is a
prerequisite for auditory scene analysis (Sohoglu & Chait, 2016), speech perception
(Grube et al., 2013; Rimmele et al., 2015), understanding complex auditory streams
(Andreou et al., 2011; Alexandra Bendixen et al., 2007b; Malmierca et al., 2014; Van
Zuijen et al., 2005; Winkler et al., 2009), as well as learning patterns and associations
(Alexandra Bendixen et al., 2007b; Winkler et al., 2009).
There is a large literature investigating pattern and association learning in PD and relative
to exogenous dopamine therapy. Despite a few exceptions (Beigi et al., 2016; Frank,
Seeberger, & O’Reilly, 2004; Shohamy et al., 2006) learning is comparable in PD patients
and healthy age-matched controls at baseline (i.e., in the OFF state) and is worsened by
dopaminergic therapy (Cools, 2006; Gallant et al., 2016; Hiebert et al., 2015; 2019;
Jahanshahi et al., 2010; MacDonald et al., 2011; MacDonald et al., 2013a; MacDonald et
al., 2013b; Pizzagalli et al., 2008; Swainson et al., 2000; Van der Schaaf et al., 2013; Vo
et al., 2018, 2014). Stimulus-reward learning (MacDonald et al., 2013), probabilistic
reversal learning (Robertson et al., 2018), stimulus-response learning (Hiebert et al., 2019,
2014; Vo et al., 2014), associative learning (Gotham et al., 1988; MacDonald et al., 2011),
and learning efficiency (Jahanshahi et al., 2010) are normal at baseline in PD relative to
age-matched controls, and are worsened by dopaminergic therapy. In fact, there is even a
small literature demonstrating detrimental effects of dopaminergic therapy on association
learning in healthy elderly (Vo et al., 2018; Breitenstein et al., 2006; Mehta et al., 2001;
Santesso et al., 2009), and younger (Hiebert, Vo, et al., 2014; Vo, Seergobin, &
MacDonald, 2017b; Vo et al., 2016) controls. Our results raise the possibility that pattern
and association learning deficits, induced by dopaminergic therapy, in PD and in healthy
controls could be related to impairments provoked by exogenous dopamine in
fundamental regularity detection and processing. Noting and exploiting statistical
regularity in the environment is a precursor to learning patterns and associations.
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Limitations
Although our study was able to disentangle differences in neural responses to regularity
processing related to aging, PD (i.e., yCT in comparison to aCT and PD), and
dopaminergic therapy, we did not collect behavioural responses signaling awareness of
regularity detection. Our interpretations here rely on previous ascertainment of a clear
relation between the sustained EEG response and a manual response indicating perception
and awareness of regularity (Barascud et al., 2016b). We extrapolate from this study to
understand our results.
Another limitation relates to the fact that we have included data of a young control group
collected in another study (Herrmann & Johnsrude, 2018b). Herrmann and Johnsrude
(2018) used the regularity detection protocol that we implemented here. They did not
introduce dopaminergic therapy as we did in our study, however. Although it would have
been optimal to obtain data in healthy young controls both off and on dopaminergic
therapy, the main aim for including performance measures from healthy young controls in
this study, whom we presume have the optimal neural response to regularity, was to
evaluate the integrity of regularity processing in healthy elderly controls and PD
participants at their baselines (i.e., in the OFF state). Indeed, this baseline comparison
revealed that regularity detection worsens with age but is not further impaired by PD.
Having not tested our young controls on dopaminergic therapy, we could not extend our
investigation of the dopamine overdose effect on regularity processing, which could have
been quite informative. The widely-supported dopamine overdose hypothesis would
predict detrimental effects of exogenous dopamine even for young healthy controls. To
this point, previous investigations of dopaminergic therapy on cognitive processing in
healthy young controls have generally shown analogous detrimental effects for healthy
young controls (Breitenstein et al., 2006; Frank & O’Reilly, 2006; Gallant et al., 2016;
Torta et al., 2009; Vo et al., 2018), healthy elderly controls (Vo et al., 2018, 2016), and
early PD patients (Cools, 2006; Hiebert, Vo, et al., 2014; A. A. MacDonald, Monchi, et
al., 2013; Vo et al., 2014). In fact, we have shown in a direct comparison, that the
magnitude of the dopamine overdose impact on probabilistic learning is equivalent in
healthy young and elderly controls, even though at baseline, healthy elderly controls
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performed more poorly than healthy young controls (Vo et al., 2018). We speculated that
these results arose because if even a minor VTA dopamine impairment occurs with aging
small exogenous dopamine doses still exceed that impairment, overdosing VTA-supplied
brain regions. Dopaminergic tone in VTA-innervated brain regions is quite similar for
healthy elderly and early-mid PD patients, because the VTA is essentially spared in earlymid PD (Haber & Fudge, 1997; Halliday & McCann, 2010). It is therefore expected that
the deficits related to exogenous dopamine observed in healthy elderly and early-mid PD
participants in our study would parallel the effect of dopaminergic therapy on regularity
processing in healthy, young controls. Overall, we feel that the limitation of failing to test
young, healthy controls on dopaminergic therapy in the current study is mitigated by our
main objective for including a healthy young control group and the extant literature on the
effects of dopaminergic therapy in healthy young versus older controls.
Finally, because our data for healthy young controls were obtained in a previous study
(Herrmann & Johnsrude, 2018b), our standard patient questionnaires and baseline
cognitive tests were not administered. However, it is worth noting that these participants
were young adults and were all undergraduate students at the University of Western
Ontario who self-reported no neurological diseases. It seems highly unlikely that this
group of healthy young undergraduates would have significant impairment in regularity
detection. Further, cognitive impairment and other clinical measures, including anxiety
and depression, were not significantly correlated with regularity detection in our healthy
elderly and PD groups. All of our measures and questionnaires did not correlate with the
sustained response, and therefore we feel this moderates the limitation that these cognitive
and clinical data were not available for the healthy young controls in our study.

Conclusion
Regularity processing is a fundamental function in auditory scene analysis and in
negotiating complex auditory environments. Deficits in detecting regular patterns can
instigate cognitive impairments including most forms of pattern or association learning.
We found that aging impaired the neural signal associated with regularity processing
assessed with EEG. PD did not worsen regularity processing above the main effect of age,
given that PD is an aging-related disorder and our healthy elderly controls were age-
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matched to our PD patients. Beyond these deficits, however, dopaminergic therapy, which
represents standard therapy for motor symptoms in PD, abolished the sustained response
in PD patients and in healthy elderly participants. This pattern of deterioration of function
related to dopaminergic therapy is a well-documented phenomenon attributed to
dopamine overdose of dopamine-replete brain regions due to their innervation by the
VTA. The VTA is relatively spared in PD and in normal aging. This coheres with the
limited literature on regularity processing, relating this fundamental process to VTAinnervated brain regions (e.g., hippocampus and IFG). The abolition of the neural
response associated with regularity processing could instigate a number of cognitive
impairments in functions that depend on regularity processing such as in association
learning and speech processing. This relation should be directly investigated in future
studies. The understanding that dopaminergic therapy impairs regularity detection and
potentially affects cognitive functions that depend upon regularity processing should be
weighed against motor symptoms in titrating dopaminergic medication in PD patients.
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3

L-Dopa alters brain activity associated with passive, not
active, regularity processing
The brain is particularly tuned to the presence of regularity (e.g., repetitions) within
auditory scenes, potentially as means of facilitating the segregation of different
superimposed auditory streams. Processing of regularity is thought to involve the
interplay of several brain areas such as the auditory cortex, inferior frontal gyrus (IFG),
and possibly the hippocampus.
We observed recently that a particular neural correlate of regularity processing, measured
with electroencephalography (EEG), was reduced in older people. In addition, 3,4dihydroxyphenylalanine (L-Dopa) reduced the same neural signal in healthy older adults
and possibly patients with Parkinson’s disease. Our study examined the effects of L-Dopa
and attention on neural signatures of regularity processing.
The aim of the current study was to investigate L-Dopa’s effects on neural signatures of
regularity in passive and attentive listening conditions. We hypothesized that L-Dopa
‘overdoses’ dopamine-replete brain regions that mediate regularity processing, even in
healthy younger adults. Given that there is a difference in the brain activity between
passively and actively listening to an auditory stimulus, we decided to investigate the how
the brain activity differs between these conditions on L-Dopa. Functional magnetic
resonance imaging was used to measure brain activity from 17 healthy young adults, once
on L-Dopa/carbidopa 100/25mg and once on placebo. Participants listened, passively and
actively, to two different auditory stimuli that consisted of short tone pips that either
contained a regularity (i.e., a repeating pattern of pitches) or were random. During the
passive condition, Off medication, primary auditory cortex and inferior frontal gyrus were
more active in the regular condition than either the random or silent condition, however,
this difference disappeared on medication. In contrast, during the active condition,
random and regular auditory stimuli were equivalent and showed similar activity in the
active condition, a pattern that was not significantly affected by L-Dopa.
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Our results complement previous studies on regularity processing and increase our
understanding of the role of L-Dopa in impairing auditory regularity processing – during
the passive but not active conditions.
Keywords: Functional magnetic resonance imaging, auditory regularity processing, dopamine
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Introduction
Analyzing visual and auditory regularities is essential for perception. Picking up on
auditory cues, for example in pitch and timbre, helps with the global scene analysis
(Bregman, 1990). In addition, regular structure of auditory stimuli is important for
auditory scene analysis (Bendixen, 2014; Winkler et al., 2009), speech perception
(Rimmele et al., 2015c), and establishing future predictions to optimize behavior
(Bendixen, 2014; Winkler, Denham, & Nelken, 2009; Zhang & Rowe, 2015).
Here, regularity processing refers to the ability to detect the presence of regular auditory
structures. Regularities within an auditory stream have been suggested to improve the
ability to detect targets, such that it is easier to detect targets in a regular sequence than a
random one. Southwell and colleagues (2017) demonstrated that a higher accuracy and
lower reaction time can be observed when detecting a target in a regular background
compared to a random one. Additionally, having a random stimulus in the background, as
opposed to a regular one, can be detrimental to performance. Random sequences are more
computationally demanding with the increasing demand on the processing resources, thus
these stimuli become more distracting and harder to ignore, compared to regular
sequences, which compromises the ability to detect targets within that stream (Southwell,
Baumann, Gal, Barascud, Friston, et al., 2017).
Humans are sensitive to the presence of regularities within the auditory stream (Bendixen
et al., 2007a; Escera et al., 2014; Grahn & Rowe, 2013; Koelsch & Sammler, 2008;
Lütkenhöner, Seither-Preisler, Krumbholz, & Patterson, 2011); however, regularity
detection declines with factors such as aging (Donohue, Weinhold, Schoenfeld, Quian
Quiroga, & Hopf, 2019; Herrmann, Buckland, & Johnsrude, 2019; Rimmele, Schroger, &
Bendixen, 2012), Alzheimer’s disease (Goll et al., 2012), and Parkinson’s disease (PD)
(Te Woerd et al., 2018), particularly when treated with dopaminergic therapy (Al Jaja,
Grahn, Herrmann, & Macdonald, 2020).
Several factors compromise or impair the ability to use regular cues in an auditory
stimulus. For example, aging is associated with a significant reduction in this ability
(Aghamolaei et al., 2018; Al Jaja et al., 2020; Alain, Ogawa, & Woods, 1996; Getzmann
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& Näätänen, 2015; Harris & Dubno, 2017; Herrmann et al., 2019; Rimmele et al., 2012).
Older adults show a significant decline in regularity processing ability, as well as a
reduction in their EEG sustained response (Al Jaja et al., 2020). The sustained response is
a regularity-related EEG response that indicates intact regularity processing ability and
can be investigated to show impairments in the auditory stream that are related to
regularity processing. Similar to aging, PD is coupled with a reduction in the sustained
response.
PD is a neurodegenerative disorder that affects more than 1 % of the population. This
disease is characterized by motor symptoms such as rigidity, resting tremor, postural
instability, and bradykinesia. PD’s motor symptoms result from the loss of dopaminergic
neurons in the substantia nigra pars compacta (SNc), with L-Dopa (l-3,4dihydroxyphenylalanine) being the gold standard in treating motor symptoms associated
with PD. However, administering L-Dopa can impair certain cognitive abilities (Coull et
al., 2012; MacDonald, Monchi, et al., 2013; MacDonald et al., 2011; MacDonald &
Monchi, 2011; Pizzagalli et al., 2008; Santesso et al., 2009; Swainson et al., 2000; Vo et
al., 2014).
With respect to EEG activity, we previously found that administering L-Dopa to PD
patients and healthy older controls reduced their regularity-associated sustained response
(Al Jaja et al., 2020). This reduction in the sustained response can translate into
impairments in regularity processing in older adults and in patients with PD, an
impairment that is further amplified on L-Dopa. However, the role of L-Dopa remains
unclear with respect to its effect on the brain structures associated with or that generate
the sustained response.
The effect of L-Dopa in the context of the dopamine overdose hypothesis has been
investigated in the context of aging and PD (Al Jaja et al., 2020; Georgiev et al., 2015;
Graef et al., 2010; Kwak, Müller, Bohnen, Dayalu, & Seidler, 2010; MacDonald,
Seergobin, et al., 2013; MacDonald & Monchi, 2011; Vo et al., 2014; Yang, Lauzon,
Seergobin, & MacDonald, 2018), with some studies probing this effect in younger adults
(Gallant et al., 2016; Vo et al., 2017b, 2018, 2016). In our study, we decided to isolate the
effect of L-Dopa on regularity processing by testing healthy younger adults on our
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experimental paradigm. Using this approach, we can explore L-Dopa’s effect on
regularity processing without interference from aging or neurodegenerative disorders.
Recent studies investigating regularity processing isolated areas involved in this ability
using different electrophysiological and imaging modalities. EEG studies have shown that
regular patterns increase the sustained response compared to random tones (Al Jaja et al.,
2020; Barascud, Pearce, Griffiths, Friston, & Chait, 2016; Herrmann, Buckland, &
Johnsrude, 2019; Herrmann & Johnsrude, 2018; Southwell et al., 2017; Teki et al., 2016).
A different approach using fMRI has located brain areas linked to regularity processing
(Barascud et al., 2016). In their study, regular patterns, compared to random
(regular>random) increased activity in the superior temporal gyrus (STG), Heschl’s gyrus,
and inferior frontal gyrus (IFG). These studies point out brain areas associated with
regularity; however, most used passive listening where participants heard the stimuli
while performing a different behavioral task. In some studies, participants attended to the
stimuli (Herrmann & Johnsrude, 2018a; Southwell, Baumann, Gal, Barascud, & Friston,
2017), but there was either an auditory or visual task with the presented stimuli that could
have diverted attention away from the intended stimuli.
Adding attention to the equation affects how we understand regularity processing. The
effect of stimuli in attracting attention, whether random, regular, or if they are
perceptually salient, has been gaining interest in the past few years (Southwell, Baumann,
Gal, Barascud, Friston, et al., 2017). Therefore, it is important to understand how attention
affects the perception of regularity and if there is any difference in brain activity when
actively vs passively attending to an auditory stimulus.
In our study, we separately examined the effect of L-Dopa on passive and active listening
in an fMRI paradigm. In the passive task, participants listened to the auditory stimuli
while watching a silent movie while in the active condition they attended to the auditory
stimuli to make a decision. This enabled us to compare the brain areas that respond to
regularity during active and passive listening. To our knowledge, this is one of the first
studies to probe the effect of passively versus actively listening to an auditory stimulus
(see also Barczak et al., 2018; Herrmann & Johnsrude, 2018b; Sohoglu & Chait,
2016).We hypothesized that exogenous dopamine would impair regularity processing by
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reducing activation in brain areas associated with regularity processing. Additionally, this
activation may be translated into behavioral changes (such as increased reaction time or
reduced accuracy) in the participants’ abilities to detect transitions between regular and
random patterns. Furthermore, given that the presence of regular patterns during the
passive and active listening is expected to attract attention differently, hence affecting our
perception of those regularities and simultaneously affecting our global auditory stream
analysis, we hypothesized that different patterns of activation would occur in the passive
and active conditions.

Methods
3.2.1

Participants and Procedure

We recruited 21 healthy young adults (n = 10 females) to take part in a two-session study
at the Brain and Mind Institute at the University of Western Ontario. Participants were
excluded if they reported any neurological disorders, clinical depression or anxiety,
substance use disorders, prior brain or spinal cord injuries, or were on medications that
interact with L-Dopa. Participants reported normal hearing with no previous hearing
problems. Four participants were excluded from the analysis due to technical problems
with the scanner and/or undesired medication side effects. The reported analyses were
conducted on 17 participants. This study was approved by the Health Sciences Research
Ethics Board at the University of Western Ontario and followed the declaration of
Helsinki.
Participants completed two MRI scanning sessions, one after single-blind pre-treatment
with L-Dopa and one after placebo. Treatment order was randomized and counterbalanced
across participants. During the first study session, participants completed a cognitive
assessment (see below) before ingesting a capsule containing L-Dopa or placebo.
Approximately 45 minutes after capsule ingestion participants completed an auditory
regularity detection task (passive and active tasks) while in the MRI scanner. The session
always started with the passive task and then followed by the active task. After the MRI
scan, participants completed questionnaires assessing anxiety, depression, and apathy.
Participants were unblinded to their treatment order after the second study session.
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3.2.2

Questionnaires

Participants completed a battery of questionnaires that assessed cognitive abilities
including the Montreal Cognitive Assessment (MoCA) and the American version of the
Nelson Adult Reading Test (ANART). In addition, participants filled the Beck anxiety
(BAI) and depression (BDI-II) inventories and the Starkstein apathy scale on both days.

3.2.3

Passive task

Auditory stimuli (Al Jaja, Grahn, Herrmann, & Macdonald, 2020; Barascud et al., 2016a;
Herrmann & Johnsrude, 2018b) were composed of sequences of short tone pips (0.04 sec)
with frequencies ranging from 700 to 2500 Hz and rise and fall times of 0.007 seconds.
No gap was presented between tones. Equal numbers of stimuli were presented for either
4, 5, 6, or 7 seconds. Stimuli were presented binaurally via MR compatible earphones
(Sensimetrics S14 Insert Earphones). Stimulus presentation was controlled by a PC
(Windows 7, 64 bit). Two conditions were created: Random (RAND), in which the
frequency of the tone pips in the stimulus sequence was randomly selected, and regular
(REG), in which the sequence of selected frequencies repeated in a pattern (Fig. 3.1).
Stimuli were presented in pseudorandom order over four blocks combining RAND, REG,
and silent (SIL, scanner noise) conditions (25 trials per condition in each block, a total of
100 trials per condition per session and 100 trials of the SILENT condition). Participants
were asked to attend to a silent movie projected on a screen in the scanner while ignoring
the auditory stimuli as much as possible. Each block lasted approximately eight minutes.

3.2.4

Behavioral task

Active trials consisted of a fixation stage in which participants fixated a black cross in the
center of the screen projected into the MR scanner via a mirror mounted on the headcoil.
Subsequently, an auditory stimulus was played binaurally, and participants pressed a
button with their index finger when they detected a transition in the structure of the
auditory stimuli (e.g., from random to regular or from regular to random). Participants
were asked to refrain from pressing the button if there was no change in stimulus
structure. Accuracy and reaction time measures were collected. Inter-trial-intervals were

85

jittered between 1000 and 4000 ms, with the fixation cross remaining on during the entire
time. Participants did not receive feedback on their task performance.
A step stimulus was introduced to estimate basic response time. The step stimuli consisted
of either a sudden step-down or step-up change in frequency and was used to baseline the
RT in the behavioral task analysis; this was done by removing any effects of motor delay
other than the stimuli interpretation and response (Barascud et al., 2016).

3.2.5

Active task

The auditory stimuli for the active task were similar to the passive stimuli, but all stimuli
were four seconds long. Two additional stimulus conditions were created. In the RANDto-REG stimuli, the sequence transitioned from random to regular, and in the REG-toRAND stimuli, the sequence transitioned from regular to random. Transitions happened at
1.6, 2.0, or 2.4 seconds (Fig. 3.1). Participants completed three blocks (5 trials per
condition in each block, total of 120 trials per session) with stimuli being RAND (15 per
session), REG (15 per session), RAND-to-REG (45 per session, three different
transitions), or REG-to-RAND (45 per session, three different transitions). Stimuli were
trial-unique with no repetitions of these stimuli occurring during the visit. Participants
focused on a black cross in the center of the screen in the scanner. Each block lasted
approximately 10 minutes, with a short break between each block.

3.2.6

Image acquisition

Imaging data were collected using a high-field 3T Siemens Magnetom Prisma with Total
Imaging Matrix MR. The system contains 204 seamlessly integrated coil elements and 64
RF receiver channels. We obtained a scout image for positioning the participant and T1
for anatomical localization. There were four passive runs and three active runs of T2*weighted functional acquisitions. One run consisted of one block of 75 trials in the
passive and 40 trials in the active condition. In the passive condition, the run lasted
around eight minutes while the active run lasted 10 minutes. One whole brain image
consisted of 43, 2.5 mm-thick slices taken every 2.5 seconds. The field of view was
oriented along the anterior and posterior commissure of the brain with a matrix of 88 x 88
pixels. Each isotropic voxel was 2.5 mm3 with echo time of 30 ms and flip angle of 90°.
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Figure 3.1: Stimulus Structure for Random (RAND), Regular (REG), Random to Regular (RAND-to-REG),
and Regular to Random (REG-to-RAND) Stimuli
Stimuli for the RAND and REG conditions consisted of epochs ranging from four to seven seconds, while RAND-toREG and REG-to-RAND were all four seconds with transitions happening randomly at either 1.6, 2.0, and 2.4
seconds (black dotted line).

3.2.7

FMRI Data analysis

Functional images were preprocessed and analyzed using Statistical Parametric Mapping
version 12 (SPM12; Wellcome Department of Imaging Neuroscience, London, United
Kingdom) and Matrix Laboratory (MATLAB, Mathworks, Inc., Natick, Massachusetts,
United States). Image preprocessing included: 1) slice-time correction, 2) realignment for
participant motion, 3) spatial normalization to the standard Montreal Neurological
Institute (MNI) template, and 4) smoothing with an 8-mm full-width, half maximum
Gaussian kernel, and high-pass filtered (0.0056 Hz).
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Individual participants’ data were modeled using fixed effects analyses in SPM12.
Subject-specific first level models included epochs representing the three auditory
conditions (REG and RAND), convolved by the canonical hemodynamic response
function. The epoch duration was defined as the time from the start of the auditory
stimulus until its termination. SIL stimulus was defined by the inter-stimulus-interval
between the different auditory stimuli. EPI volumes associated with discrete artifacts were
included as covariates of no interest (nulling regressors). This included volume
displacements >4 mm or spikes of high variance in which scaled volume to volume
variance was 4 times greater than the mean variance of the run. General linear model
(GLM) was created to investigate the regional blood oxygenation level dependent
(BOLD) activity associated with the auditory stimuli relative to the rest of the trial
elements in a block. Contrast images were collected and examined together at the group
level using a full factorial analysis 2x2 repeated measures ANOVA with medication (ON
vs OFF) and auditory condition (RAND, REG) being the within subject variable. Post-hoc
analyses followed by a paired sample t-test in SPM12.

3.2.7.1

Passive Contrasts

In the passive condition, we examined both the effects of stimulus type (REG and RAND)
and medication (OFF and ON). We first contrasted whole brain activity for the
REG>RAND conditions off and on medication combined. We then inspected the
medication effect by contrasting REG and RAND-ON>REG and RAND-OFF. Following
that, we were interested in the cluster size difference between REG and RAND
conditions, therefore we compared the activated cluster during the REG and RAND
conditions. Finally, we investigated the individual differences between REG and RAND
both OFF and ON medication by comparing REG (ON-minus-OFF) and RAND (ONminus-OFF), separately.

3.2.7.2

Behavioral data analysis

We analyzed the behavioral results using a 2x2 repeated measures analysis of variance
(ANOVA) with conditions (RAND-to-REG vs REG-to-RAND) and medication (OFF vs
ON) as within subject variables. Post-hoc analysis using Tukey’s test was performed to
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investigate the individual condition and medication effects. To remove any latency in
relation to the motor response, the average reaction time from the step stimulus was
subtracted from the average reaction time for the actively transitioning auditory stimuli to
baseline the data. The latency includes the time taken for the stimulus to reach awareness
and generate the motor response.

3.2.7.3

Active Contrasts

For this analysis we combined the REG conditions with the REG part of the epoch from
the REG-to-RAND stimuli. Similar combination was done for the RAND conditions
where the RAND part of the RAND-to-REG epoch was combined with the RAND
stimuli. We ran a 2x2 repeated measures full factorial ANOVA with conditions (RAND
vs REG) and medication (ON vs OFF) as within subject variables. Furthermore, we
analyzed condition by medication interactions. The condition main effect was analyzed by
contrasting regular and random conditions (REG>RAND) across on and off medication.
We then contrasted ON-minus-OFF medication (ON>OFF) across REG and RAND
conditions. Furthermore, the interactions between condition and medication were
analyzed.

Results:
3.3.1

Health and demographic information

Health and demographic information were collected from all participants (Table 3.1). This
sample consisted primarily of university students with low scores on average for anxiety,
depression, and apathy. All participants reported normal hearing and no previous
psychological or neurological problems.
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Table 3.1: Health and demographic information (N = 17).
OFF

ON

p value

Age

22.26 (3.14)

--

MoCA

28.50 (1.60)

--

AMNART

122.67 (8.25)

--

BAI

4.25 (6.39)

3.55(5.92)

0.18

BDI

4.10 (4.20)

3.55(2.96)

0.37

Starkstein Apathy Scale

9.40 (5.17)

9.47(4.14)

0.96

Note. Values represent Mean (SD). MoCA = Montreal Cognitive Assessment, AMNART = American
version of the Nelson Adult Reading Test, BAI = Beck Anxiety Inventory, BDI = Beck Depression
Inventory.

3.3.2
3.3.2.1

Passive task
Stimuli effect

In the passive condition, to ensure that the stimuli elicited the expected auditory activation
we contrasted auditory conditions with silence (REG&RAND> SIL). This contrast
showed significant bilateral activation of the STG (anterior and posterior divisions),
Heschl’s gyrus (H1 and H2), planum polare, planum temporale (Table 3.2).
Next, we inspected the condition effect (REG>RAND). We expected that REG would
elicit a different activation pattern from RAND, but no significant difference was found.
However, the REG cluster of activation was larger in spatial extent than the RAND (Fig.
3.2). Compared to the RAND condition, the REG cluster extended to the posterior STG,
Heschl’s gyrus, planum polare and planum temporale bilaterally (p<0.05, uncorrected); at
p<0.001, this activation only was evident in the REG condition in the left planum
temporale, STG posterior division, Heschl's Gyrus (includes H1 and H2), and MTG.
However, this activation was not found in a direct comparison of REG and RAND
conditions (REG>RAND).
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Table 3.2 Significant brain activation comparing the presented stimuli (REG and RAND) to
silent (SIL) ON and OFF medication (concatenated).
Contrast

Anatomical Area

Cluster size

p*

T value

Coordinates (mm)
X, y, z

Passive: Condition
(REG&RAND)minus-SIL

Left STG, Planum Polare,
Planum Tempolare,
Heschl's gyrus

237

0.001

5.72

-57, -22, 5

Right STG, Planum Polare,
Planum Tempolare,
Heschl's gyrus

233

0.005

5.36

66, -13, 5

Cluster size is reported in voxels. P values are reported at a significant level of p<0.001 uncorrected at the voxel
level. Coordinates are reported in the MNI space.

3.3.2.2

Medication effect

To compare the medication effect, we contrasted all auditory conditions in the ON
compared to the OFF state. ON > OFF and OFF > ON contrasts resulted in no significant
differences at a corrected level. At p<0.001 uncorrected, ON > OFF activity was observed
in the inferior temporal gyrus and right superior frontal gyrus (Table 3.4), and OFF>ON
activity was observed in the left hippocampus and temporal lobe (STG, planum polare,
planum temporale, and Heschl’s gyrus). The lower activity in the ON state compared to
the OFF state may indicate an attenuation from L-Dopa (Table 3.5). However, this
activation difference did not survive FWE correction.

3.3.3

Behavioral results

Behavioral measures were analyzed using a 2x2 repeated measures ANOVA with
medication and condition as within subject variables. As expected, participants detected
the change to randomness quicker than detecting change to regularity (F = 258, df = 1,
p<0.01). L-Dopa did not affect accuracy or reaction time (F = 0.002, df = 1, p>0.05).
Additionally, the medication vs condition interaction was not significant (F = 0.25, df = 1,
p>0.05) (Fig 3.3).

91

Z=2

Figure 3.2: Activation clusters off
medication for both regular and
random conditions.

Y=-12

X=-50

Group activation for REG (orange)
and RAND (blue) superimposed on
a structural template image axial
(z=2), coronal (y=-12), and sagittal
(x=-50). P<0.05 (uncorrected).
These results did not survive FWE
correction at 0.05; however, at
p<0.001 uncorrected, REG
condition showed activity in the left
STG, Heschl’s gyrus, and Planum
Temporale, which was not present
during the RAND condition

REG
RAND

Table 3.3 Brain regions active during REG auditory stimuli only.
Anatomical area

T value

p (uncorrected)*

Coordinates (mm)
x

y

z

Left STG, Planum Temporale

5.00

<0.001

-63

-31

11

Right STG, Planum Temporale

4.27

<0.001

69

-28

14

Right STG, Planum Polare

4.13

<0.001

54

2

-7

Left Heschl's gyrus

3.88

<0.001

-57

-13

-1

Left Heschl's gyrus

3.39

<0.001

-54

2

-7

Right IFG, Pars Trianglurais

3.88

<0.001

45

17

14

* Results are thresholded at p < 0.001 uncorrected. Coordinates are reported in the MNI space.
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Table 3.4 Areas that exhibited higher activity in the ON vs OFF state in the Passive task
(ALL auditory conditions ON>OFF) at p<0.01 uncorrected.
Cluster size
T value

p (uncorrected)

Coordinates
(mm)
x

y

z

Cerebellum

4.55

24

p<0.001

18

-67

-40

Right Insula

4.04

11

p<0.001

42

-4

-1

p<0.001

45

-52

-7

Right Inferior
Temporal Gyrus
Right Superior
Temporal Gyrus

4
3.71
3.56

4

p<0.001

15

29

41

3.44

10

p<0.001

15

23

50

Table 3.5 Areas that exhibited higher activity in the OFF vs ON state in the Passive task
(ALL auditory conditions OFF>ON) at p<0.01 uncorrected.
T value

Cluster size

p (uncorrected)

Coordinates
(mm)
x

y

z

Left Hippocampus

4.14

7

p<0.001

-24

-40

5

Temporal lobe

3.14

2

p<0.001

-57

-28

5
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*

1500

OFF

Time (ms)

ON

1000

500

0
REG-to-RAND

RAND-to-REG

Figure 3.3 Average reaction time for correct responses
Reaction time for stimuli that transitioned from regular to random (REG-to-RAND) and random to regular
(RAND-to-REG) and both OFF and ON L-Dopa, averaged across durations. Participants responded faster to
the transition from REG to RAND both in the OFF and ON states (p<.05). Medication did not have any
significant effect on the ability or speed of detection of these transitions.

3.3.4

Active Stimuli

In the active condition, where participants attended to the stimuli and responded by a
finger press, the main effect of condition (REG>RAND) produced no significant
activation differences. Inspecting the medication effect (ON>OFF), we found activation in
the left superior and middle frontal gyri, left hippocampus, and right IFG (threshold of
p<0.001, uncorrected); however, this activation did not survive FWE correction. The
reverse contrast (OFF>ON medication) did not show any significant activation.
Exploratory analysis on the difference between REG and RAND in the OFF medication
only showed activation in the STG, hippocampus, caudate, and putamen (Table 3.6).
However, this activity did not survive FWE correction. ON medication, this contrast
(REG>RAND) did not show any significant activation.
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Table 3.6 Areas that exhibited higher activity in the REG >RAND conditions at p<0.05
uncorrected.
p
T value (uncorrected)

Coordinates
x

y

z

Left Hippocampus

2.31

0.013

-15

-1

-13

Left STG

2.26

0.014

-60

-1

-4

Right Hippocampus

2.13

0.019

30

-25

-13

Left MFG

2.11

0.02

-45

41

26

Left Cerebellum

1.72

0.045

-18

-31

-22

1.7

0.046

-21

8

-10

Right Amygdala

1.69

0.048

21

2

-19

Right Caudate

1.68

0.048

6

11

2

Left Putamen

Discussion
3.4.1

Summary of results

Although the differences we found were not statistically significant, we were able to
observe anecdotal evidence that regular patterns activated brain areas differently while
OFF compared to ON and while attending to the stimulus in question. However, given
that regularity processing results in higher sustained response and different activation
patterns, we can safely assume that we are making a legitimate claim in comparing the
medication effect in these subjects. In the current study, we found higher activity during
the passive condition in areas involved in regularity processing, such as the STG and IFG,
although this activation did not survive correction (Barascud et al., 2016; Sohoglu &
Chait, 2016; Southwell, Baumann, Gal, Barascud, Friston, et al., 2017). Additionally, LDopa reduced the brain activity in the regular condition during the passive task. When off
medication, compared to on medication, whole brain analysis showed trending higher
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activity in the STG and left hippocampus that did not survive correction. Behaviourally,
participants were able to identify the transition from regular to random more readily than
from random to regular, which was expected. Participant’s responses to this transition
were not affected by administering L-Dopa. Additionally, we found that when participants
actively attended to only the auditory stimuli, the difference in activity was not significant
when comparing random and regular contrasts. In other words, attending to the auditory
stimuli resulted in similar brain activity both OFF and ON medication.

3.4.2

Medication effect

Introducing exogenous L-Dopa to the participants altered the brain activity related to
regularity processing, especially in the passive condition (STG, Heschl’s gyrus, and
hippocampus). This alteration was evident by the decrease in activity in the ON state
compared to the OFF state. In contrast, during the active condition, administering L-Dopa
resulted in higher activity in the STG, MTG, left hippocampus, and right IFG.
Previously, we have found that introducing L-Dopa to healthy older controls attenuated
the EEG sustained response associated with regularity. Additionally, the alteration in the
EEG response was similarly evident in patients with PD (Al Jaja, Grahn, Herrmann, &
Macdonald, 2020). The possible effect observed in the passive case could be attributed to
the dopamine overdose hypothesis. This hypothesis explains the effect of L-Dopa in the
body as an inverted U-shape curve, whereas a lower dose of the medication (for example
in case of PD) results in impairment in motor symptoms; however, a higher dose of LDopa results in some minor cognitive impairment. This impairment is due to the
overdosing effect dopamine has on the ventral striatum, which receives projections from
the ventral tegmental area, which is the area most impacted by the overdosing effect
(Cools, 2006; MacDonald & Monchi, 2011). Unlike the VTA, the SNc projections to the
dorsal striatum are not prone to overdosing and that is why L-Dopa improves motor
symptoms associated with PD. The same principle can explain the observed activity
change in our study. This reduction in activity, although correlated with behaviour, may
be due to the presence of exogenous dopamine overdosing the VTA.
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The reason we suspect that the VTA, not the SNc, is involved in regularity processing stems
from the fact that participants experienced a significant attenuation in brain activity when
ON medication in areas involved in regularity processing. The SNc/dorsal striatum stream
does not experience any overdosing due to its ability to accommodate any increase in
dopamine. In contrast, the VTA, along with its downstream projections, are prone to
overdosing of dopamine, even in low doses.
Additionally, Cameron and colleagues (2016) found that medication had a two-fold effect
in a behavioural study of rhythm discrimination. On the one hand, L-Dopa improved the
discrimination in simple beat-based structures (i.e., regular sound stimuli). On the other
hand, discrimination in complex beat-based structures (i.e., irregular sound stimuli) was
impaired. Although the study was confounded by the medication order (patients were
always tested first OFF medication then ON medication), there might be an effect with
respect to medication. In principle, Cameron and colleagues expected an improvement in
the second session, regardless of the medication state. However, a relative decline was
observed for the complex stimuli. This implies that medication might have worsened the
ability to detect complex beat structures that are random or complex in nature. This
conclusion is in line with our results regarding the negative effect of L-Dopa on ability on
regularity processing, which might be a precursor for more complicated processing, such
as beat perception, and more cognitively demanding processing, such as speech perception.

3.4.3

Attention effect on regularity processing.

In our study, we aimed to investigate the effects of attention on regularity processing. When
attending to the auditory stimulus the brain activity was not significantly different when
comparing REG and RAND. The similarity in the neural activation between these two
stimuli suggests that attention increases the predictability effect and thus reduces the
surprise effect provoked by the passive listening (Sohoglu & Chait, 2016; Zhang & Rowe,
2015). In other words, during the active condition, there was a form of expectation triggered
by diverting attention towards those stimuli and hence the changes were to some extent
expected. In this aspect, attention and expectation became similar in terms of top-down
processing.
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When expectation is guided by attention, we can understand the reason for the previously
shown attenuation. Take, for example, mismatch negativity (MMN) studies on the role of
expectation in the auditory modality. In their study, Chennu et al., (2013) found that when
participants attended to regularities, the MMN response was attenuated, which reflects a
“top-down” pattern of processing. Thus, we suggest in our study that attention blurred the
distinction between attention and expectation resulting in a similar activation pattern
between REG and RAND, unlike what we saw in the passive condition.
Although at odds with the general role of attention in auditory processing (E. S. Sussman,
Horvath, Winkler, & Orr, 2007; Zhao & Luo, 2017), our study is consistent with
observations from previous studies (Schwartze, Rothermich, Schmidt-Kassow, & Kotz,
2011; Sohoglu & Chait, 2016; Spratling, 2008). The main difference between our study and
Sohoglu & Chait, (2016) is that in their study the scene-evoked response (i.e., stimuli that
did not transition from RAND to REG) showed similar activation. In contrast, our study
showed a greater neural response to REG compared to RAND stimuli in the passive
condition but not in the active one.

Limitations and future directions
Although our hypotheses are partially supported by the fMRI patterns found, behaviorally,
we were not able to see any medication effect. Additionally, some of the participants were
not able to finish the entire session, which made us unable to collect some of the active data.
More importantly, due to the nature of the presented stimuli and the visual interference in
the passive condition and motor interference in the active one, we did not have a direct
comparison between the passive and active tasks, which limits our interpretations of the
difference between passive and active regularity processing. Future studies should
investigate the impairment associated with L-Dopa in disease related populations using
fMRI. This approach will help us pin the exact location where regularity is affected in aging
and PD and how L-Dopa specifically affects these areas.
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Conclusion
Unlike active listening, passive listening revealed the neural activity represented in
response to the presence of regularities. Additionally, dopaminergic replacement reduced
the regularity effect in passive, not active, conditions. The impairment linked to exogenous
dopamine here can be attributed to the dopamine overdose theory, which implicates several
cognitive and possibly auditory aspects in PD.
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4

Alprazolam reduces freezing of gait (FOG) and improves FOGrelated gait deficiencies
We investigated the effect of acutely reducing anxiety with the benzodiazepine,
Alprazolam, on freezing of gait (FOG) in patients with Parkinson’s disease (PD).
Freezing of gait (FOG) is a disabling and incapacitating motor symptom that results in
falls and impairs the quality of life of more than 50% of later-staged patients with PD.
FOG consists of brief episodes of an inability to initiate or continue walking, and is
characterized by short and stuttering steps, occurring particularly at gait onset or upon
changes in direction or speed of ambulation. This symptom is relatively intractable, with
minimal response to dopaminergic therapy. Anxiety is associated with FOG (for a review
see Witt, Ganjavi, & Macdonald, 2019). This is consistent with patients’ subjective
reports of experiencing anxiety during episodes of FOG, as well as with the fact that
stressful or anxiety-inducing situations provoke FOG (Ehgoetz Martens et al., 2014).
Ten patients with PD and FOG participated in the current study. In two sessions, on
separate days, patients walked on a pressure-sensitive walkway (ZenoTM) in virtual
environments, created using WorldViz software and presented via Oculus Rift virtualreality goggles. Trials were designed to moderate or provoke anxiety. In the Low Anxiety
(LA) condition, participants walked on a plank that appeared level with the floor. In the
high-anxiety (HA) conditions, the plank appeared raised. Alprazolam (0.25mg) and
placebo were administered in identical capsules, in separate sessions. We assessed the
impact of anxiety (LA vs. HA) and Alprazolam-related anxiety reduction (Alprazolam vs.
Placebo) on a modified version of the BAI, blood pressure (BP), heart rate (HR), the
frequency of FOG, step velocity, step length, and swing time, as well as on the
coefficients of variation of step length, step time, and step width.
Alprazolam reduced objective measures of anxiety (i.e., systolic BP and HR). FOG was
experienced only during the high anxiety conditions. Further, Alprazolam marginally but
significantly reduced the number of patients experiencing FOG in HA conditions. It
increased swing time and reduced gait variability associated with reduced FOG.
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Our results support that 1) anxiety aggravates FOG in patients with PD, and 2) Alprazolam
reduces anxiety and FOG, as well as improves gait parameters associated with freezing.
Our research suggests that anxiety is a causal factor of FOG in PD.
Keywords: Parkinson's Disease, Freezing of Gait, Anxiety, Alprazolam, Virtual reality.
A version of this chapter has been submitted to Movement Disorders
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Introduction

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the
degeneration of dopamine producing neurons in the substantia nigra pars compacta (SNc)
resulting in different motor and cognitive impairments. The cardinal symptoms of PD are
resting tremor, rigidity, bradykinesia, and postural instability. Additionally, PD patients
are more prone to developing a debilitating symptom identified as freezing of gait (FOG).
FOG is a disabling and incapacitating symptom that often results in falls and impairs the
quality of life of more than 50% of later-stage PD patients. This symptom is characterized
by short stuttering steps that slow patients’ walking and will often result in a complete
stop (W Dauer & Przedborski, 2003; Jankovic, 2008; Kalia & Lang, 2015b; Walton,
Shine, Mowszowski, & Naismith, 2014). This gait impairment bears grave consequences,
including falls, loss of autonomy, and decreased quality of life.
Unfortunately, FOG responds poorly, if at all, to the regular PD treatments, including
dopaminergic replacement therapy (Giladi et al., 2007). In general, response of FOG
symptoms to dopaminergic replacement therapy has been divided into three categories:
dopamine-resistant, -induced, or -responsive (Nonnekes et al., 2015). However, this
response is dictated by multiple factors, most importantly, the disease duration, with later
disease duration responding more poorly than earlier stage. Nevertheless, the
pathophysiology underlying FOG remains unclear.
Multiple theories have been proposed for FOG in PD, yet none of them provides a full
understanding of the pathophysiology of freezing. Four models that explain FOG are
widely discussed. These include the 1) threshold, 2) decoupling, 3) cognitive, and 4)
cross-talk models. The two prevailing hypotheses in detailing the role of factors such as
cognition and emotion in gait are the cognitive and the cross-talk models of FOG. The
former explains FOG in the context of elevated cognitive load, for example as when
patients perform a serial subtraction task while walking. It was postulated that cognitive
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load splits processing resources, impacting gait, a complex cognitive and motor function.
Alternatively, the cross-talk model proposes interfering interactions among networks
underlying motor, cognitive, and limbic (e.g., emotion fear, anxiety) functions adversely
affect gait. According to Ehgoetz Martens and colleagues (2014), anxiety was highly
correlated with FOG and was suggested as a causal factor in the production of FOG.
FOG has been associated with heightened levels of anxiety (Ehgoetz Martens et al., 2014;
Jochen Vandenbossche et al., 2011; Witt et al., 2019). In a study directly examining the
effect of anxiety on FOG, researchers contrasted the performance of patients with PD with
and without FOG, walking in two virtual reality environments that differed in their
potential for inducing anxiety. PD patients with FOG reported higher levels of anxiety
compared to those without FOG when walking through the high anxiety scenario
(Ehgoetz Martens et al., 2014). In addition, PD patients with FOG experienced
significantly more FOG episodes and spent more time frozen during the high anxiety
(HA) condition as well. In terms of gait measures, anxiety impaired gait by decreasing
velocity, shortening step length, and increasing step length- and step time-variability. This
study provided direct evidence that anxiety can induce FOG, affording a validated
experimental paradigm for testing whether reducing anxiety would lead to reductions in
FOG and gait parameters related to FOG.
Anxiety can be managed using pharmacotherapy, psychotherapy, or a combination of
both. Focusing on pharmacotherapy, first line treatments for disordered anxiety include
selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake
inhibitors (SNRIs), buspirone, monoamine oxidase inhibitors (MOA-I), and, for acute
effects, benzodiazepines. Benzodiazepines acutely and effectively decrease the experience
of anxiety and its physiological manifestations in a number of conditions such as
generalized anxiety, social anxiety, phobias, and panic attacks. Further, benzodiazepines
are first line treatment in patients with hyperekplexia, a neurological condition in which
excessive startle to tactile or acoustic stimuli leads to increased tone and freezing that at
least on the surface bears some resemblance to FOG in PD. Benzodiazepines have been
shown to be safe and effective in the treatment of anxiety in PD. Though not first choice
for long-term use due to sedating effects, dependence, and abuse potential,
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benzodiazepines reduce anxiety quickly, reversibly, and following a single dose. These
properties of benzodiazepines make them highly favourable for initial investigations of
the effects of modulation of anxiety/physiological effects of anxiety, on behaviour.
Alprazolam is one of the fastest-acting benzodiazepines, with a short half-life of 9 to 30
hours (Sankar, 2012), that has been extensively used to successfully alleviate anxiety and
its objective, measurable physiological manifestations, in many conditions (Ait-Daoud,
Hamby, Sharma, & Belvins, 2016; Fawcett & Kravitz, 1982; Sankar, 2012).
The objective of our study was to test the effect of reducing anxiety and alleviating its
associated physiological manifestations on FOG, to further our understanding of the
relation between anxiety and FOG. Given our aims, benzodiazepines and Alprazolam in
particular, appeared optimal for these initial investigations. To our knowledge, no
previous studies have tested the effect of anxiety alleviation, or specifically of
benzodiazepines on FOG. We hypothesized that reducing anxiety would decrease the
frequency and severity of freezing in PD patients with FOG.

Methods:
In PD patients known to experience FOG, we investigated the effect of Alprazolam
compared to placebo on FOG and gait parameters associated with FOG, in separate
sessions, tested in counterbalanced order across participants. All participants in this study
were able to ambulate without an assistive device for more than 10 meters and were not
on any medications that interact with Alprazolam. The study was double blind, with both
patients and experimenters blind to conditions. Both Alprazolam (0.25mg) and placebo
(i.e., cornstarch), were administered in identical capsules. Patients diagnosed by a
neurologist with PD, who were treated with dopamine-modulating therapy, were recruited
through the Movement Disorders Database, London Health Sciences Centre. All
participants were evaluated in two, nearly-identical sessions at the Brain and Mind
Institute, University of Western Ontario. In both sessions, they were treated with their
usual dopaminergic therapy. Three patients were excluded from the study due to their
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inability to tolerate the virtual environment or Alprazolam (n=3). Statistical analysis was
performed on the remaining group (n=10, 4 females).
Half of the participants received Alprazolam at their first session followed by placebo at
their second session, and the other half participated in sessions that were in reversed
order. Alprazolam and placebo caplets were provided an hour prior to tests of gait.
Patients provided demographic and clinical information prior to testing (Table 4.1). In
addition, during both sessions, participants completed a battery of questionnaires aimed at
assessing FOG (NFOG questionnaire), anxiety (Beck Anxiety Inventory), depression
(Beck Depression Inventory-II), Montreal Cognitive Assessment (MoCA), American
National Adult Reading Test (ANART), Bond-Lader visual analogue scale of alertness,
verbal fluency test, and sleepiness scale. Finally, unified Parkinson’s disease rating scale III (UPDRS-III) was performed by the experimenter approximately an hour after capsule
administration. UPDRS scoring was performed by a licensed neurologist, with movement
disorders training (P.A.M). Patients’ health and demographic information, as well as their
cognitive measures, were collected prior to administering Alprazolam.
An hour following the ingestion of the capsule in each session, we obtained a baseline
measure of ambulation, in which participants walked on the gait mat (GAITRite mat)
without any goggles. This allowed us to assess the effects of Medication (i.e., Alprazolam
vs. Placebo) and the virtual environment itself on gait. Following ambulation in the
Baseline condition, participants wore Oculus Rift VR goggles (Facebook Inc., California,
USA) and walked along a ~ 4.5 m long GAITRite mat (CIR systems Inc., Sparta, USA),
which was used to collect gait variables and objectively identify episodes of freezing and
effects of Alprazolam versus placebo on gait parameters associated with FOG. The
participant was tracked and the viewpoint in the VR environment was updated in real time
using three Oculus sensors (Facebook Inc., California, USA). The different VR
environments were constructed using the VR software, Vizard (Worldviz L.L.C., Santa
Barbara, USA).
Patients (n=13) ambulated in virtual reality scenarios designed to mitigate or evoke
anxiety [i.e., Low anxiety (LA) and High anxiety (HA), respectively], as demonstrated by
Ehgoetz Martens et al., 2014. During the LA condition, patients walked on a virtual plank
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that appeared level with the floor. There were two HA conditions: HA-Pit and HA-Plank.
In the HA-Pit condition, patients ambulated along a plank over a simulated 2.5 m deep pit.
In the HA-Plank condition, patients walked across what appeared to be an elevated plank
(2.5 m), suspended in midair (Fig. 4.1). The plank width, length, and appearance were
identical in all virtual conditions and was superimposed on the GAITRite mat.
Each session was divided into 6 blocks. Each block contained five pseudorandomlyassigned trials, either LA, HA-Pit, or HA-Plank while ensuring all patients were subjected
to equal number of trials and anxiety scenarios. A trial consisted of traversing the entire
4.5 m walkway from the starting point to the end of the mat while wearing virtual reality
goggles. At the beginning of each block, patients were asked to stand approximately one
meter away from the beginning of the mat, at what appeared to be the edge of the plank.
The goggles were then fitted comfortably on patients. The lights were turned off to
prevent any interference from external stimuli and the virtual condition was presented. At
the end of each block, participants were seated and asked to complete a version of the
BAI and BDI-II modified to focus on anxiety and mood during the preceding block.
Their level of sedation was also assessed with the Bond-Lader visual analogue level of
alertness. Finally, blood pressure (BP) and heart rate (HR), constituting our objective
measures of anxiety, were also collected at the end of each block.
A)

B)

C)
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Figure 4.1: Virtual environments in which PD patients ambulated.

Low anxiety (A), High anxiety–Pit (B), and High anxiety–Plank (C); trials were pseudorandomly presented to patients, each block contained a combination of the three scenarios.

In the event that a) systolic blood pressure dropped by 20 mmHg relative to baseline or
fell below 90 mmHg, or b) pulse increased or decreased by 20 beats per minute, patients
would be withdrawn from the study. In no instances were these conditions met. To further
ensure the safety of the patients, one or two lab associates, depending on the needs of the
patient, walked alongside them during each plank-walking trial, throughout the entire
experiment. Though a support person was present on each trial, they did not talk to or
touch patients, nor did they interfere with performance in any way. Only on one occasion
in this experiment did a lab volunteer intervene to support a patient who reported feeling
dizzy. The experiment was stopped with no incident and the patient’s data were excluded
from the study. We speculate that this low incidence of side effects was due to our
screening procedures in this experiment. Though we specifically recruited patients with
FOG, we excluded any patients who could not reliably walk 10 meters without the use of
a gait aid evaluated based on self-report measures. Further, participants were screened at
the beginning of each session for any cognitive impairment, history of falls, brain or
spinal cord surgeries, and were closely observed by the examiner to confirm their ability
to walk unassisted.

4.2.1

Anxiety and Gait measures:

Anxiety measures were collected using the BAI. A modified version of the BAI was
administered after each block and thus the instructions were altered, tailoring them to the
experimental setting and for repeated assessment following each block, in an attempt to
measure fluctuating anxiety levels and capture any changes in anxiety levels pertinent to
participation in trials of this study. Objective measures of anxiety included systolic blood
pressure and heart rate. The Bond-Lader visual analogue scale was also introduced
between blocks to ensure the patients were tolerating the medication and were not
becoming sedated.
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Measuring FOG in experimental settings has proven challenging. Previous studies have
quantified FOG measuring frequency and duration of the episodes of gait dysfunction. A
FOG episode was identified when gait velocity decreased between zero and one standard
deviation of the average velocity for each trial. In keeping with previous studies, trials that
contained FOG episodes were not included in the statistical analyses of other gait
variables (Ehgoetz Martens et al., 2014). This was done to prevent significant variability
in the results on these other gait parameters. Additionally, to replicate Ehgoetz Martens et
al (2014) and to ensure equal representation of all VR scenarios, we analyzed the first five
trials for each condition.
PD patients with FOG are known to have deficits in multiple gait measures, including
velocity, step length, and swing time. Swing time refers to the time taken from when the
toes leave the ground to when the heel hits the ground again. These variables, which are
aberrant in patients with FOG were included as dependent variables in our analyses.
Additionally, gait variability, such as the coefficient of variation of step length, step time,
and step width were calculated. We investigated the impact of anxiety on these FOGrelated measures (Almeida & Lebold, 2010b; Ehgoetz Martens et al., 2014).
Gait measures were separated into spatial and temporal gait measures and gait variability
which was defined as the coefficient of variation (CV). The spatial measures were the
stride length which was the distance between the heels of two consecutive foot-steps of
the same foot and was measured in cm. The temporal measures were the stride time,
which is the time taken for one full gait cycle (e.g., right foot heel strike to the following
right foot heel strike) measured in seconds and cadence measured as steps/m.
Additionally, we investigated our manipulation on gait velocity which is a spatiotemporal
parameter of gait measured identified as distance walked/time walked and measured in
m/s. Finally, gait variability was investigated. Gait variability was measured as a
percentage (% of CV). A more stable gait has been linked to longer stride length, faster
stride time, faster gait, with longer swing times. Moreover, having lower variability
translates to more stable and better gait.

4.2.2

Statistical analysis
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In the case of BAI, BDI-II, BP, and heart rate analysis (HR), 2x7 repeated measures
analyses of variance (ANOVAs) were conducted with Medication (ON vs OFF) and
Blocks (Pre-Admin and Blocks 1 to 6) as within-subject variables. To analyze the gait
data, we ran 2x4 repeated measures ANOVAs with both Medication (Alprazolam vs.
Placebo) and Condition (Baseline, LA, HA-Pit, and HA-Plank) as within-subject
variables. In cases of sphericity violation, Greenhouse-Geisser correction was
implemented. We further pursued planned single degree of freedom contrasts (e.g.,
Baseline vs. Final Block for anxiety measures). Simple effects were also investigated
using Tukey’s Honest Significant Difference (HSD) post hoc t-tests in the cases of main
or interaction effects.

Results:
4.3.1

Health and Demographic

We recruited 13 patients to take part in this study (4 females). Patients were diagnosed
with PD and all experienced FOG by self-report through screening questions and for the
majority, episodes of freezing were observed in the clinical setting as well. According to
the NFOG questionnaire, which is a measure of freezing of gait in PD, patients recruited
were mild to moderate freezers with scores ranging from 4 to 14 (Table 4.1). Patients did
not suffer from any cognitive impairments. We imposed a cut-off of 26 on a MoCA
administered on the first day of testing. The latter was a safety consideration given our
procedures and the introduction of a benzodiazepine in one session of the experiment.
Further, this avoided any potential confounding effects of cognitive impairments related
to FOG, gait performance, anxiety, and anxiety-reducing medication. Inclusion and
exclusion criteria were reviewed before experimental testing of any patients. A list of
health and demographic information, as well as questionnaire scores, were also collected
and are presented in (Table 4.1).

4.3.2

Subjective anxiety measures: BAI

First, we analyzed the data across all blocks by running a 2x7 repeated measures ANOVA
with Medication (Alprazolam vs Placebo) and Block (Pre-Admin vs Blocks 1 to 6) as
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within-subject variables. No significant main effect of Medication [F(1, 7)=0.27,
MSe=18.71, p=0.61] was observed. Additionally, there was no main effect of Block, with
BAI scores being statistically equivalent across blocks [F(1, 6)=0.943, MSe=4.47,
p=0.475]. Finally, there was no Medication x Block interaction [F(1, 6)=0.64, MSe=3.68,
p=0.69]. Note that the degrees of freedom are 7 and not 9 because two of the subjects did
not fill one of the questionnaires during the session.
We further performed two sets of planned, single-degree-of-freedom contrasts. First, we
compared Baseline levels of BAI (i.e., after medication was administered but before VR
goggles were introduced) to the Final Block BAI both on Alprazolam and on Placebo
using a paired sample t-test. No significant difference was observed between Baseline and
Final Block for Placebo [t(9)=0.73, p=0.44] or Alprazolam [t(9)=1.99, p=0.08]. BAI
results on Alprazolam, however, were trending towards a significant anxiety reduction.
We further investigated changes in anxiety levels using BAI before administering Placebo
or Alprazolam and pre-Baseline walking without VR goggles (i.e., pre-Baseline) relative
to the Final Block levels. The difference between pre-Baseline and last Block BAI scores

Table 4.1: Health and demographic information for PD patients with FOG.
Mean ( SD)
Age (years)

68.7 (1.97)

Disease duration (years)

6.4 (4.68)

NFOG

10 (3.36)

MoCA

27.50 (1.50)

LEDD

886 (385.5)

Oxford Happiness

4.25 (0.61)

Verbal Fluency

Animals

F

13.30 (4.29)

A

12.10 (5.36)

S

14.70 (6.14)
19.90 (4.81)
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ANART

124.56 (5.62)

Sleepiness

8.80 (5.54)

Results are reported as means (±SD). NFOG = New Freezing of Gait Questionnaire; MoCA =
Montreal Cognitive Assessment; LEDD = Levodopa equivalent Daily Dose, ANART = American
National Adult Reading Test.

LEDD = L-Dopa dose + (L-Dopa dose x 1/3) if on entacapone + (bromocriptine (mg) x 10)
+ (cabergoline or pramipexole (mg) x 67) + (ropinirole (mg) x 20) + (pergolide(mg) x 100)
+ (apomorphine (mg) x 8)

were investigated for both Placebo and Alprazolam. Using paired t-tests, analogous to
what we performed for Baseline and Final Block, we found no significant difference in
the Placebo session, t(8)=0.793, p=0.448, though the difference was significant in the
Alprazolam session, t(8)=2.205, p<0.05. The latter contrast was the only true measure of
the effect of Alprazolam on anxiety as assessed with BAI modified to fit our experimental
situation. This finding confirms that we succeeded in reducing anxiety by introducing
Alprazolam.

4.3.3

Objective heart rate and blood pressure measurements

To investigate patients’ HR, we ran a 2x7 repeated measures ANOVA with Medication
(Alprazolam vs Placebo) and Block (Pre-Admin and Blocks 1 to 6) as within-subject
variables. HR measures did not show an effect of Medication [F(1,7)=2.35, MSe=116.29,
p=0.16] nor Block [F(1,6)=0.59, MSe= 11.76, p=0.73]. Additionally, we did not observe
any Medication x Block interaction [F(1, 6)=1.62, MSe=6.28, p=0.16]. As a follow-up,
we ran a paired-sample t-test on the Baseline (Alprazolam vs Placebo) and Final block
(Alprazolam vs Placebo). As expected, at Baseline, Placebo and Alprazolam were not
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statistically different [t(9)=0.32, p=0.75]. Interestingly, at the Final Block, Alprazolam
showed a significant reduction in HR compared to Placebo [t(9)=2.54, p=0.03].
Systolic BP was analyzed using a 2x7 repeated measures ANOVA with Medication
(Alprazolam vs Placebo) and Block (Pre-Admin and Blocks 1 to 6) as within-subject
variables. There was no main effect of Medication [F(1,7)=1.83, MSe=75.32, p=0.27],
with Alprazolam not having a significant effect on BP. Additionally, main effect of Block
was approaching significance [F(1,6)=2.16, MSe= 124.20, p=0.06] (Fig. 4.2). Finally,
there was no interaction between Medication and Block [F(1,9)=1.56, MSe=120.038,
p=0.18]. A paired sample t-test on the Baseline (Alprazolam vs Placebo) and Final Block
(Alprazolam vs Placebo) reading of systolic BP was conducted. This analysis showed that
BP did not change between the Baseline and Final Block neither on Placebo nor on
Alprazolam [t(8)=-1.29, p=0.23 & t(8)=1.32, p=0.22, respectively)]. As a follow-up, we
compared the difference between Baseline and First Block (Baseline-Final) on Placebo
and Alprazolam. We noticed that on Placebo BP readings increased significantly between
these two readings [t(8)=2.43, p=0.04]. More importantly, we observed that on
Alprazolam, BP readings did not differ between these two readings [t(8)=-0.55, p=0.59].
This means that Alprazolam was able to prevent an elevation in the BP associated with
the anxiety inducing scenarios that are presented after baseline gait measures.
Moreover, Bond-Lader results did not show any effect of Medication, Block, or
interaction between Alprazolam and Block (all F<1), suggesting that these physiological
effects are not simply related to sedating effects of Alprazolam.
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4.3.4
4.3.4.1

Gait measures:
Freezing of gait episodes:

Episodes of FOG were defined as periods during which the velocity dropped between
zero and one standard deviation of the average velocity, calculated for each participant per
Session and Condition (Cowie, Limousin, Peters, Hariz, & Day, 2012; Ehgoetz Martens et
al., 2014). FOG episodes occurred only during the HA trials, with none arising in the LA
scenarios or in the Baseline events, producing a significant main effect of anxiety [F(2,18)
=8.82, MSe= 4.53, p<0.01]. In terms of the frequency of FOG, medication did not have a
main effect [F(1,9)=0.11, MSe=7.03, p=0.74]. Additionally, there was no interaction
between Medication and Condition (F(2,18)=0.11, MSe= 7.03, p=0.89). During the HA
scenarios, however, patients experienced 21 FOG episodes on Alprazolam compared to
28 episodes on Placebo. Assessing presence vs. absence of FOG, we conducted an exact
binomial probability analysis. With three patients experiencing FOG in the Alprazolam
session compared to six in the Placebo session, the difference was marginally significant
(p=0.05).

Medication
Placebo

Figure 4.2: Systolic blood pressure change on Alprazolam and Placebo from Baseline (before
administering Alprazolam or Placebo).
We did not observe any Medication or Block effect on the 2x7 ANOVA. Further analyses were done to
investigate Baseline vs Block 6 (Final Block) changes. On Placebo, there was a noticeable increase in
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BP, specifically between Baseline and Block-1. In contrast, Alprazolam managed to stabilize BP
preventing a significant elevation. Error bars represent SEM.

4.3.4.2

Swing time:

One of the most important gait stability measures is the swing time, which is the time
taken from when the toes leave the ground to when the heel hits the ground again. Our
2x4 ANOVA with medication (Alprazolam vs Placebo) and conditions (Baseline, LA,
HA-Pit, and HA-Plank) as within-subject variables showed a main effects of Medication
[F(1,9)=12.57, MSe=0.0004, p = 0.006] and Condition [F(3,27)= 11.79, MSe=0.0008,
p=0.005; Greenhouse-Geisser corrected]. Patients have consistently displayed a reduction
in swing time when the anxiety conditions were introduced. Following Alprazolam
administration, we noticed a significant prolongation of swing time in all three virtual
conditions. There was no significant interaction between Medication and Condition
[F(3,27)=1.83, MSe=0.0001, p=0.15]. Post-hoc analyses showed that Alprazolam
increased the swing time in all virtual conditions (Fig. 4.3). In the LA condition, swing
time significantly increased on Alprazolam compared to Placebo [t(9)=2.45, p=0.03].
Similarly, Alprazolam increased swing time for both HA conditions compared to Placebo
[HA-Pit: t(9)=3.07, p=0.01; HA-Plank: t(9)=2.77, p=0.02].
Other direct gait variables, such as step length, step time, and cadence were not
significantly affected by Alprazolam (Table 4.2).
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Figure 4.3 Difference in Swing Time.
There were main effects of Condition [F(1,9)=11.79, p = 0.004] and Medication
[F(3,27)=12.57, p = 0.006]. Paired sample t-tests for HA-Pit and -Plank (Placebo vs
Alprazolam) and LA (Placebo vs. Alprazolam) conditions showed an increase in Swing
time when patients were on Alprazolam relative to Placebo for both Pit and Plank
conditions, [HA-Plank: t(9)=2.79, p = 0.02; HA-Pit: t(9)=3.07,p=0.01; and LA: t(9)=2.45,
p=0.03]. Baseline was similar on both Medication states [t(9)=1.08, p=0.30].

4.3.4.3

Gait variability:

We conducted a 2x4 ANOVA with Medication (Alprazolam vs Placebo) and Conditions
(Baseline, LA, HA-Pit, and HA-Plank) as within-subject variables for both gait variability
measures (Stride time- and Stride velocity-CV). As mentioned previously, gait variability
can be an important indicator of gait abnormalities that can be associated with FOG in
PD. We found distinct effects on gait variability of Medication and Condition. There was
no main effect of Medication on Stride time-variability [F(1,9)=1.41, MSe=6.38, p=0.26].
However, higher anxiety increased stride time CV, evidenced by a main effect of
Condition, [F(3,27)=19.19, MSe=6.80, p<0.001, Greenhouse-Geisser corrected]. Further,
there was a Medication x Condition interaction [F(3,27)=3.87, MSe=2.26 p=0.03,
Greenhouse-Geisser corrected]. Following Tukey’s post-hoc tests, we found that
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Alprazolam significantly reduced stride time CV in the HA-Plank condition [t(9)=-2.72,
p=0.02], but this effect was not seen on the LA or HA-Pit conditions (Fig. 4.4).
Moreover, stride velocity CV have shown similar results. There was no main effect of
Medication [F(1,9)=1.268, MSe=22.96, p=0.289]. A main effect of Condition [F(3,
27)=26.369, MSe=9.46, p <0.001, Greenhouse-Geisser corrected] was found showing a
Table 4.2: Repeated measures 2x4 ANOVA for gait variables.
Main effect of medication (Alprazolam vs Placebo), Condition (Baseline, LA, HAPit, and HA-Plank), and interactions are included.

Variable name

Step Length

Step Time

Cadence

Comparison

F

df

p

Main effect of Medication

0.03

1

0.85

Main effect of Condition

33.83

3

<0.001

Medication vs Condition
Interaction

2.12

3

0.16

Main effect of Medication

2.72

1

0.13

Main effect of Condition

1.58

3

0.21

Medication vs Condition
Interaction

2.48

3

0.09

Main effect of Medication

3.59

1

0.09

Main effect of Condition

1.05

3

0.38

Medication vs Condition
Interaction

1.16

3

0.34

significant increase in variability when higher anxiety scenarios were introduced.
Interestingly, we found a Medication x Condition interaction [F(3,27)=4.025, MSe=29.38,
p=0.034, Greenhouse-Geisser corrected]. Further analyses have shown a significant
reduction in Stride velocity-CV following the administration of Alprazolam, specifically
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in the HA-Plank condition [t(9)=-2.391, p=0.040], but not in the HA-Pit nor in the LA
conditions (Fig. 4.5).

Figure 4.4: Stride time coefficient of variation for patients on Placebo and on
Alprazolam.
No significant main effect of Medication was observed. There was a main effect of
condition (p<0.001) and a condition by medication interaction (p=0.02). Paired samples ttest between HA-Plank conditions showed significant reduction of Stride time CV on
Alprazolam compared to Placebo (t=-2.72, p=0.02).
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Figure 4.5: Stride velocity coefficient of variation for patients on Placebo and on
Alprazolam.
There was a main effect of condition (p<0.001) and a condition x medication interaction
(p=0.01). Paired samples t-test between HA-Plank conditions showed significant
reduction of Stride velocity CV on Alprazolam compared to Placebo (t=-2.39, p=0.04).

Discussion:
FOG is a symptom in PD that greatly impacts quality of life. Anxiety is suggested as a
significant contributor to FOG. Our objective was to investigate the effect of a) increasing
anxiety through VR scenarios and b) of reducing anxiety pharmacologically, on FOG and
gait parameters linked to FOG, in PD patients who were cognitively intact but who were
known for FOG. Replicating Ehgoetz Martens and colleagues (2014), we found that VR
scenarios in which patients had the impression that they were walking a suspended plank
a) increased subjective (modified BAI) and objective (HR, Systolic BP) measures of
anxiety, as well as b) increased the incidence of FOG, c) reduced spatial and temporal
parameters associated with stable gait, and d) increased gait variability. FOG appeared
only in HA conditions, which supports the contention that anxiety provokes freezing.
Moreover, anxiety-provoking trials (i.e., HA-Pit and HA-Plank) showed the most
significant decrease in stride time and length, as well as a significant reduction in gait
velocity. Taken together, altering anxiety, confirmed using subjective and objective
measures, impacted FOG and gait parameters related to stability and FOG. These findings
support claims that anxiety is a mediating factor of FOG in PD.
In addition to providing a replication of the findings of Ehgoetz Martens and colleagues
(2014), (but see also Yamagami et al., 2020), we further investigated whether
pharmacological reduction of anxiety could impact episodes of FOG and/or related gait
abnormalities. First, we confirmed that Alprazolam had the intended anxiolytic effect. As
expected based on previous studies of the effect of Alprazolam (Jonas et al., 1993;
Moylan et al., 2011), administering low-dose Alprazolam to PD patients with FOG
reduced anxiety as measured subjectively (i.e., modified BAI scores) and objectively (i.e.,
HR and systolic BP) compared to Placebo. A modified version of the BAI was used as our
subjective measure of anxiety in this study. We amended instructions to ask patients about
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their anxiety specifically at pre-Baseline (i.e., before Baseline gait measures were
obtained, and prior to administration of Placebo or Alprazolam), as well as at the end of
each block, in which participants walked with VR goggles. We found that modified BAI
scores measured pre-Baseline, prior to ingestion of Alprazolam, were decreased relative
to Placebo when measured at the end of each block of virtual gait trials. Physiological
measures, as indices of anxiety, seemed more sensitive, unsurprisingly, than our
modification to the BAI measure.
Alprazolam is not known for reducing HR in baseline conditions, but it's effects on HR
were not studied following acutely anxiety-provoking events (Van Den Berg et al., 1996),
as was the case in the current study. However, the effect of Alprazolam on reducing
systolic BP has been long established (McLeod, Hoehn-Saric, Zimmerli, De Souza, &
Oliver, 1990; Van Den Berg et al., 1996). Anxiety, fear, and stress are all factors that
contribute to HR and BP elevation. As objective evidence that Alprazolam produced the
expected effect of anxiety reduction, we found that upon introducing Alprazolam, we
noticed a stabilization of systolic BP and a reduction in HR. In contrast, in the Placebo
condition, BP increased when participants began ambulating with VR goggles and
experiencing intermixed blocks of LA, HA-Pit, HA-Plank, compared to Baseline
ambulation. Providing further context, Alprazolam did not reduce levels of alertness that
were measured at the end of each block, as well, casting doubt that sedation per se
produced these changes. In this way, all measures of anxiety were consistent in
confirming that even low-dose Alprazolam had its intended anxiolytic effect.
The effect of Alprazolam on FOG was also clear. Alprazolam decreased FOG episode
frequency though not significantly. The number of patients who experienced FOG in the
HA scenarios was reduced in the Alprazolam compared to the Placebo sessions (p=0.05).
Alprazolam also had positive effects on most gait parameters that are associated with
FOG such as Swing time and measures of gait variability (Barbe et al., 2014; J. M.
Hausdorff et al., 2003). Alprazolam increased Swing time compared to Placebo in HA and
LA conditions. Compared to the Baseline trials (i.e., walking the mat without goggles),
even LA scenarios impaired gait parameters, although to a lesser extent than the HA
scenarios. This increase in Swing time, which is essentially a measure of the time spent
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with one foot on the ground and the other mid-air, indicates a more stable and betterbalanced gait. Gait variability was also reduced on Alprazolam compared to Placebo,
particularly as measured by Stride time-CV and Stride velocity-CV but only in the HA
conditions. Alprazolam-related reduction of gait variability was noted in the HA
conditions, particularly the HA-Plank condition. Moreover, our VR anxiety manipulation
was successful in eliciting FOG in the HA scenarios, with no freezing happening in either
the Baseline or LA conditions. Binomial analysis revealed that Alprazolam reduced the
number of patients that experienced FOG compared to when they performed in the
Placebo session. Additionally, frequency of FOG episodes was lower on Alprazolam
compared to Placebo (21 and 28, respectively), although this measure did not reach
statistical significance.
Considering information presented in the preceding paragraphs, we have empirically
demonstrated that a) inducing anxiety, dramatically increases episodes of FOG (i.e., no
FOG occurred in Baseline or LA conditions), b) introducing Alprazolam reduces
subjective and objective measures of anxiety, without increasing levels of sedation, and c)
Alprazolam reduces episodes of FOG, as well as improves Swing time, Stride time
variability, and Stride velocity variability (only in the HA conditions for the latter two gait
measures). Taken together, we interpret these findings as evidence that pharmacological
reduction of anxiety, improves gait in PD patients with FOG, including reducing the
number of PD patients who experience FOG. This introduces the possibility for new
strategies for treatment of FOG—a particularly intractable symptom leading to falls, and
ultimately the loss of independent ambulation and function.
We did not observe any improvement in Stride time, Stride length, or Gait velocity in our
study. The average Stride time has been found to be similar between PD patients with and
without FOG, though Stride time variability, which was improved by Alprazolam in our
study, was more pronounced in the FOG group (Hausdorff et al., 2003). The lack of
effect of Alprazolam on some direct spectral and temporal gait variables, with clear
improvements particularly in measures of gait variability (e.g., stride time and stride
velocity coefficient of variation), could suggest that these variables are more related to
FOG than others. Again, we expect that an anxiolytic effect will impact FOG and perhaps
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gait variables that are associated with FOG but there is not an expectation based on the
literature that all PD gait abnormalities will be improved. This requires greater
exploration in future studies.

4.4.1

Effect of Anxiety on Gait in PD

Anxiety has clearly been linked to FOG in the past decade (Ehgoetz Martens et al., 2014;
Lewis & Shine, 2016; Nonnekes et al., 2015; Vercruysse et al., 2012; Witt et al., 2019).
Most of these studies are correlational and anxiety has not been identified to be a causal
factor in inducing FOG. However, Ehgoetz Martens et al., (2014) developed an
experimental manipulation that suggested anxiety could cause FOG, thus creating a
paradigm that could be used to study the causality of anxiety in FOG. Distinct visual
experiences were needed to create the HA and LA conditions, however, and given that
visual/sensory cues are known to induce FOG, this did create a possible confound. The
current study strengthens their work and their claim that anxiety plays a causal role in
FOG. In the current study, we evaluated anxiety’s etiological role in FOG, in conditions
that were identical with respect to their visual/sensory experiences as well as physical
demands, by directly reducing anxiety with a pharmacological intervention. In this way,
we extend the investigations of Ehgoetz Martens et al., (2014), supporting the contention
that anxiety induces FOG, and further, that reducing anxiety decreases FOG.

Increasing anxiety, using VR scenarios, and then decreasing anxiety with Alprazolam,
also had effects on swing time. Swing time, as previously explained, is the time taken
from when the toes are off the floor until the heel again strikes the floor. Previous studies
on the effect of swing time on gait stability (Baltadjieva, Giladi, Gruendlinger, Peretz, &
Hausdorff, 2006; Muñoz Ospina et al., 2019; Zanardi et al., 2021), have shown that longer
swing times translate to more stable gait, which in turn translates into reduced chances of
falls and incapacitation. Reduced swing times are associated with greater walking
instabilities resulting in falls and incapacitation (Baltadjieva et al., 2006). Swing time was
significantly reduced in all virtual conditions (LA, HA-Pit and -Plank). Introducing
Alprazolam prolonged patients’ swing time on all virtual scenarios. PD patients usually
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have reduced swing time compared to healthy older controls (Zanardi et al., 2021). In our
study, we found that the virtual environment and particularly those that produced higher
anxiety significantly reduced swing time compared to baseline (i.e., walking without the
VR goggles), which meant patients were spending less time mid-air and hence they had
less stable walking. In contrast, in the Alprazolam session, we found that swing times
were increased in all conditions, except obviously Baseline, prior to the administration of
Alprazolam. This is evidence that gait is being stabilized by Alprazolam. To our
knowledge, this is one of the first studies that connects anxiety with swing time
modulation. We have shown that in PD with FOG, Alprazolam increases Swing Time and
therefore makes gait more stable, independent on its effect on FOG. Whether this relation
holds in PD without FOG or other groups remains to be investigated.
Gait variability is another important indicator of gait stability and relates to both falls and
incapacitation. Higher gait variability has been correlated with increased FOG frequency
and severity. Previous studies have shown increased variability in several gait variables
including stride time CV (Jeffrey M Hausdorff, 2005), stride length CV (Blin, Ferrandez,
& Serratrice, 1990; Galna, Lord, & Rochester, 2013; Knobl, Kielstra, & Almeida, 2012),
step time (Almeida & Lebold, 2010), as well as a decrease in swing time (Jeffrey M
Hausdorff, 2005; Zanardi et al., 2021), and increase in cadence (Zanardi et al., 2021),
which correlated with FOG, gait instability, and risk of falling. Theoretically, improving
any of the aforementioned measures, could translate into reduced FOG. Improvements in
these measures, leads directly to more stable gait. In our study, stride time CV and stride
velocity CV were both reduced (i.e., improved) in the Alprazolam condition compared to
Placebo in the HA-Plank condition only. The reason for this difference could have been
due to the level of anxiety for the HA-Plank vs HA-Pit. We did not directly measure
subjective anxiety related to these different HA conditions. Future studies could aim to
disentangle these effects.

4.4.2

FOG in PD

FOG is a complicated symptom in PD. Several models have aimed to explain the
pathophysiological mechanism underlying FOG. The threshold, the decoupling, the
cognitive, and the cross-talk models have proposed different mechanisms of FOG.
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However, both the threshold (Plotnik, Giladi, & Hausdorff, 2012) and decoupling models
(Jacobs, Nutt, Carlson-Kuhta, Stephens, & Horak, 2009) fail to explain the upstream
causes of FOG. Moreover, competing inputs from the cognitive, motor, and limbic loops
are thought to be the main inputs to the striatum. Therefore, overloading the striatum by
either increasing the cognitive (i.e., the cognitive model; Rochester, Galna, Lord, & Burn,
2014) or the limbic (i.e., cross-talk models; Nutt et al., 2011) loads is predicted to produce
FOG. Our results, along with others (Almeida & Lebold, 2010; Ehgoetz Martens et al.,
2014) support the cross-talk model of FOG. We found that manipulating the limbic load,
by increasing (e.g., using VR HA conditions) or reducing (e.g., with Alprazolam) anxiety,
modulated FOG and FOG-related gait measures. Our intervention, by introducing
Alprazolam, reduced anxiety and significantly improved gait outcomes. This evidence
helps us better understand the pathophysiology behind FOG in PD, as well as suggests
potential interventions to alleviate FOG.
PD patients with FOG are more likely than those without FOG to experience frontal
executive dysfunctions (Nutt et al., 2011). As previously mentioned, FOG is common in
anxiety-provoking situations. However, what is posited is that these situations also require
a switch in motor programs (Nutt et al., 2011). The ability to quickly change motor
programs in response to external stimuli (e.g., walking down a narrow hallway or passing
through a door) is thought to depend on basal ganglia processing of the competing limbic,
motor, and cognitive loops (Nutt et al., 2011). This does not directly support the findings
of the current study but demonstrates the similarity in the means by which ‘cognitive
overload’, as suggested by the cognitive load model of FOG, and ‘limbic overload’, can
overwhelm the processing capacity of the dopamine-depleted striatum and induce FOG in
PD. Thus, by reducing anxiety, and hence reducing the limbic overload, we reduce the
overflow of information to the striatum. Although motor symptoms predominate in PD,
the ability of cognitive and limbic features to both provoke and relieve FOG episodes
further emphasizes the convergence of these pathways in the striatum, impacting motor
symptoms of PD, including but not limited to FOG (Lewis et al., 2009). Anxiety is a wellknown precipitant of tremor in PD (Tyrer & Lader, 1974) and in general (Tyrer & Lader,
1974).
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4.4.3

Summary

To sum up, in this study we were able to replicate other studies in inducing FOG by
anxiety provoking scenarios. Moreover, we are advising a new approach to improve FOG
in patients with PD. Due to anxiety’s direct effect on freezing, targeting it
pharmacologically might improve FOG and FOG-gait parameters. Currently FOG is
grouped under the general motor symptoms of PD, and as such is treated with the only
treatment for PD at our disposal, which is dopamine replacement. However, dopamine
replacement has not been very effective in treating FOG. Our results suggest exploration
of a whole new avenues of therapies for FOG. Alprazolam, in a single, low dose directly
improved FOG and other gait impairments related to FOG such as Swing time, and
measures of gait variability. These latter gait impairments, in and of themselves lead to
less stable gait and more proneness to falls. In other words, anxiety alleviation might
improve not only FOG but gait stability overall in PD patients with FOG. Whether these
positive impacts would extend to PD patients without FOG remains to be explored.
Alprazolam was used here because it can reduce anxiety very acutely and for only a brief
period. Alprazolam was therefore an ideal candidate drug for our aims of assessing the
impact of anxiety alleviation on gait in PD patients with FOG. In the long-term, however,
Alprazolam would not be an appropriate treatment for FOG in PD. Alprazolam has
multiple side effects that can actually contribute to falls, particularly drowsiness,
dizziness, and light-headedness (Fawcett & Kravitz, 1982). Our study was therefore
intended as a proof of concept that reducing anxiety itself can ameliorate FOG in PD.
Future studies should investigate the effect of more tolerable anxiolytics such as selective
serotonin reuptake inhibitors (SSRIs) on FOG and gait in PD. In our study, three of our
patients were already treated with SSRIs. Whether more optimized dosing could lead to
improved gait in these patients remains an open question. Given the intractability and
danger of FOG in PD, attempts to modulate anxiety, in light of our results and those of
Eghoetz Marten et al., (2014), seems warranted.
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Limitations and future directions:
Our study suggested that reducing anxiety can improve FOG and FOG-related gait
measures in patients with PD and FOG. The current study included a small sample of
highly homogenous PD patients, who had FOG but no cognitive impairment. FOG is
often seen in the setting of cognitive impairment, but we were concerned about
introducing Alprazolam in patients who were cognitively impaired. This reduced the pool
of PD patients from which we could safely draw, but the homogeneity of the sample
might have increased our ability to detect significant effects of our manipulations. Next
steps would involve observing the effect of pharmacological anxiety reduction in PD
patients with FOG with and without cognitive impairment, to ensure that our findings
generalize to the population of PD patients with FOG.
The randomization of the virtual scenarios (LA, HA-Pit and -Plank) rather than blocking
these conditions likely reduced the effect of our HA conditions. Further, the subjective
BAI measures could have been better correlated with gait effects. The BAI is a not
intended as a measure of acute changes to anxiety. In the current study, we modified the
instructions to probe anxiety changes from one block to another. Future studies should use
more sensitive and granulated measures of subjective anxiety. Physiological effects in
our study were more sensitive to anxiety promotion and reduction. Future studies should
include these objective measures of anxiety as well as subjective assessments. In fact,
continuous monitor of physiological measures would have created a better understanding
of the relation between subjective anxiety assessment, our anxiety provoking and
alleviating interventions, and gait measures.

Conclusion:
In conclusion, anxiety-provoking VR scenarios increased episodes of FOG as well as
worsened gait parameters related to stability and FOG. A fast-acting benzodiazepine,
Alprazolam, reduced FOG and improved gait stability measures. The benefit of
Alprazolam in this first investigation of anxiolytics on FOG is that it permitted fast and
brief modulation of anxiety to directly measure its impact in a controlled environment.
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Reducing FOG and improving gait stability in PD will reduce falls and increase
independence. Trials to explore more tolerable and long-lasting anxiety alleviation as a
therapy for FOG and gait impairment in PD seem warranted based on our current
findings.
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5 General Discussion
Summary of results
Using different electrophysiological, behavioral, and imaging techniques, we were able to
examine the effects of aging, PD, and dopaminergic medication on regularity processing,
which is believed to be essential for auditory stream segregation and underlies several
higher order cognitive and perceptual abilities. Generally speaking, the auditory stream is
essential for survival. Detecting minute changes in a busy stream can aid in escaping
stressful, undesired, or even dangerous situations.
In Chapter 2, we collected data from healthy young and old adults as well from PD
patients. We found that regularity processing ability is significantly impaired in the aging
population compared to healthy young controls. Similarly, PD patients displayed
alteration in that process when OFF medication, which was equivalent to healthy older
adults. Interestingly, introducing L-Dopa further attenuated the sustained EEG response in
both healthy older subjects and PD patients. At this stage, healthy young adults were not
tested on L-Dopa. The outcome of the study in Chapter 2 supported a role of aging and
the dopaminergic system in auditory stream segregation, in particular in regularity
processing. The impact of aging and PD were observed when these two groups showed a
significant reduction in the EEG sustained response. Interestingly, PD patients did not
show any additional attenuation of that response when they were off medication for 12-16
hours. What drives the role of the dopaminergic system is that administering a capsule
containing L-Dopa further attenuated the sustained response in both the aging and PD
groups. This pattern of results, impairment when ON L-Dopa compared to when OFF LDopa supports the role of the VTA, not the SNc/DS, in regularity processing.
To further investigate the effect of L-Dopa, irrespective of aging or neurodegeneration, on
regularity processing, we conducted an fMRI study (Chapter 3) in healthy younger adults.
Subjects were tested both ON and OFF L-Dopa. In this study, introducing L-Dopa to
healthy younger adults did not affect the behavioral response associated with regularity
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but it changed the pattern of activation potentially suggesting a detrimental effect on
regularity processing, specifically in the passive condition, when subjects were asked to
ignore the auditory stimuli and focus on the visual stimulus. During the passive task,
healthy younger participants showed higher activity for the REG vs RAND condition. The
higher activity for REG compared to RAND was not present when subjects were on LDopa. This further supports a role of the VTA and not SNc/DS in regularity processing.
Further, attending to the auditory stimulus did not show any difference between REG and
RAND conditions, with no effect of L-Dopa on that activation. Which means that L-Dopa
had an effect when subjects were passively, not actively, listening to the auditory stimuli.
The overdosing hypothesis is a prevailing hypothesis in Parkinson’s that explains the
effect of exogenous dopamine on functions related to areas being overdosed by dopamine,
particularly areas downstream of the VTA (meso-cortico-limbic areas). The brain regions
receiving innervation from the VTA through the meso-cortical pathway include the
hippocampus and IFG, areas that are highly correlated with regularity processing
(Barascud et al., 2016).
Moreover, we theorized a new way to reduce FOG in patients with PD. In Chapter 4, we
discussed the impact of anxiety on FOG and possible ways to ameliorate this motor
symptom in PD. In this study, patients with PD+FOG were recruited. We induced anxiety
for those patients by asking them to walk in a virtual environment that had either low or
high anxiety conditions. Anxiety significantly increased FOG frequency and worsened
FOG gait-related parameters in PD patients. This impairment was partially corrected after
the administration of Alprazolam, a known anxiolytic in the benzodiazepine’s family.
Alprazolam significantly reduced anxiety, reduced FOG, and improved gait related
parameters that are associated with freezing.

Regularity processing and auditory scene analysis
The auditory scene is complex, the processing of which requires the interplay of several
cortical and subcortical structures. For example, to decipher what is being discussed by a
nearby group or differentiate between several auditory streams or even detect a sudden
threat that requires an immediate reaction, we need to accurately and successfully
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segregate sound mixtures into discrete and meaningful streams. We need to analyze the
auditory scene using spectral and temporal aspects of the environment to understand our
surroundings and to make decisions or respond to a stimulus as simple as someone calling
our name.
Successful stream segregation is believed to be dependent in part on the underlying
temporal structure of a sound (Elhilali, Ma, Micheyl, Oxenham, & Shamma, 2009;
Elhilali & Shamma, 2008; Teki et al., 2016; Winkler & Czigler, 2012; Winkler et al.,
2009). The presence of regular structures within the auditory stream stabilizes the
auditory streams (Bendixen, Schroger, & Winkler, 2009; Bendixen, 2014; Bendixen et al.,
2013; Bendixen, Roeber, & Schröger, 2007) and acts as a cue for stream segregation,
which is essential for the analysis of auditory inputs. In other words, the presence of
regular structures would be beneficial not only when present in the target stream, but
when present in the background, enabling us to improve stream segregation and attend to
a relevant stream while ignoring an irrelevant one. Moreover, regularity processing is
believed to play a role in higher cognitive abilities such as speech perception and
comprehension.
While using the EEG and fMRI paradigms, we were able to investigate how regularity
processing, a precursor for auditory scene analysis, can be altered. In the aging and PD
groups, as well as in these groups when on L-Dopa, we found that an attenuation in the
sustained response. Although there were no behavioral differences, our results indicate
that the dopaminergic system plays a role in regularity processing and can be later studied
to see its effects on higher auditory processing abilities.

Regularity and temporal structure in speech perception
Speech in its essence is a set of phonemes, a string of letters with distinct sounds, that are
combined with different onsets, durations, and pauses, to create a context that conveys a
specific meaning. This phonological processing depends on the difference in temporal
structures of those phonemes. Therefore, it is important to be able to use temporal cues
from speech to process and understand language (Poeppel, 2003; Specht, 2014). As such,
deficits in temporal processing ability can translate into improper speech perception and
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comprehension (Rimmele, Sussman, & Poeppel, 2015). Identifying the rapidly changing
temporal structures in speech, for example differentiating stop consonants, pauses in
speech, or different places of articulation, is the basis of speech perception.
Speech comprehension requires the interplay of several subcortical structures such as the
BG, cerebellum, and anterior insula (Specht, 2014). As PD progresses, the ability to
automatically recognize speech is significantly impaired. Patients with PD have shown
deficits in language comprehension, which can be contributed to the fronto-striatal
network that includes the VTA and its frontal projections (Holtgraves & McNamara,
2010). This deficit can also explain the loss of automaticity noticed in our study with
older subjects and patients with PD.
Furthermore, the planum temporale is involved in the processing of speech as well as the
processing of early auditory structures. The planum temporale is dubbed as a
computational hub that analyses complex sound structures by using the spectral and
temporal structures of sounds. Specifically, it was evident that there is a left hemisphere
preference for rapidly changing acoustics and right for tonal processing (pitch for
example) (Specht, 2014). Therefore, the activation of this brain region when regular
stimuli are presented is consistent with a role for planum temporale in regularity
processing. In our study, healthy younger adults on L-Dopa did not show any difference
between REG and RAND conditions, and effect that was evident when subjects were off
medication, particularly in areas extending beyond the primary auditory cortex to the
planum temporale. which supports our conclusion that the dopaminergic system is
involved in regularity processing, which underlies other cognitive abilities.

Aging and regularity processing ability
The findings from Chapters 2, that the sustained response is attenuated in aging and PD
groups compared to healthy younger adults and when ON compared to OFF medication,
on the effect of aging on the auditory system are in-line with several studies on the
general effect aging has on the auditory stream segregation. Temporal processing for
example is significantly affected in the aging population. It is harder and more taxing for
the elderly population to successfully segregate temporally adjacent auditory stimuli
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(Aghamolaei et al., 2018; Rimmele et al., 2015; Rimmele, Schroger, & Bendixen, 2012;
Stothart & Kazanina, 2016). But more importantly, these auditory deficits are associated
with aging irrespective of any peripheral hearing loss.
Deviant detection, a form of regularity processing, is impaired in older controls.
Aghamolaei (2018) found that deviant detection is impaired in the aging population.
Older adults show a significant reduction in their MMN amplitude related to an
impairment in deviance detection. MMN reduction might have revealed an insufficiency
of lower stage auditory system in regularity encoding. This lower-level impairment results
in diminished functioning at higher levels of the auditory hierarchy. One of the
postulations explaining this reduction is the loss of inhibition at the level of the auditory
cortex. The age-related reduction in GABA levels might cause the reduction in inhibition
of the auditory cortex downstream projections (Amenedo & Díaz, 1998). Another
hypothesis is that the diminishing of white matter in the prefrontal cortex results in this
disinhibition (Stone et al., 2009; Yamada et al., 2003). According to Aghamolaei (2018),
regularity encoding along the auditory hierarchy is inefficient which results in deviance
detection impairment in the lower stages and diminished functioning at the higher stages
of the auditory hierarchy in the aging population. Our results are in line with studies on
MMN deviance detection, especially that we can observe a significant attenuation in older
adults, which hypothetically point towards an impairment in the regularity processing
ability.
Sequential grouping, another form of regularity processing, enables us to group auditory
sounds based on their location or temporal relation. This grouping techniques has been
suggested to be impaired in the elderly population (Rimmele et al., 2012). Older adults in
this study were unable to capitalize on certain regularities for better stream segregation
compared to their counter healthy younger adults (Rimmele et al., 2012). Additionally, the
same population requires more time to successfully isolate competing auditory inputs,
particularly speech in noise, which has been correlated with the ability to extract certain
regularities, detecting patterns, and segregating competing auditory inputs from the global
auditory stream. In our studies, we do not study a specific form of regularity processing;
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however, we can certainly say that regularity processing in aging is impaired and further
studies can utilize tasks that specifically studies each regularity processing components.
Losing the ability to properly segregate auditory streams is highly correlated with aging,
regardless of the hearing ability. Older adults and PD patients both showed a reduction in
the sustained response. Studies investigating auditory scene analysis in older adults have
also proposed an impairment in stream segregation, which could be attributed to auditory
sensory memory deficits (Rimmele et al., 2015c; Rimmele, Schröger, & Bendixen,
2012b), selective attention towards stimuli (Aghamolaei et al., 2018; Alain et al., 1996;
Christiansen, 2014; Dinces & Sussman, 2017), improper inhibitory processes of irrelevant
sounds (Snyder & Alain, 2007; Stothart & Kazanina, 2016).

Regularity processing in PD, the role of the
dopaminergic system
Having similar reductions in the sustained activity between the older adults and PD
patients suggests involvement of the VTA/VS stream rather than the SNc/DS. If regularity
processing was related to downstream projections of the SNc/DS, then we would expect a
reduction in the sustained response in PD patients when they were off medication, which
was not the case. In contrast, L-Dopa in the older controls and PD patients further
attenuated the sustained response, supporting that 1) L-Dopa is involved in some aspect of
regularity processing, otherwise we would not see this attenuation and 2) the VTA/VS
stream is more involved in regularity processing than the SNc/DS. The exogenous
dopamine in the healthy older controls and PD patients likely caused an overdose of
dopamine in striatal or downstream areas associated with regularity processing, which
resulted in the alteration in brain activity. Given that we do not have a behavioral task to
support our claim in this study, in the future we are planning on studying the effect of LDopa in a more complex auditory and behavioral task.
From our studies we can conclude the following regarding regularity processing: PD
patients and older controls having similar attenuation of the sustained response when OFF
medication indicates that the SNc and DS are not highly involved in auditory scene
analysis and in the regularity processing ability. If that was the case, PD patients would
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have shown a more pronounced impairment compared to the older adults when off
medication. Because of the pattern of degeneration in PD with the SNc degenerating in a
faster and more aggressive way than the VTA, functions related to the SNc/DS (motor
functions for example) are significantly impaired. Our results do not mirror an impairment
in the SNc/DS stream in relation to regularity; they point towards an involvement of the
meso-limbic-cortical pathways related to the VTA.
In contrast, administering L-Dopa in Chapter 2 resulted in an attenuation in the sustained
response for both older controls and PD patients. This reduction in the sustained response
amplitude can be explained by an effect on the fronto-striatal network governed by the
dopaminergic system. Dopamine may have overdosed those networks. With respect to the
pattern of degeneration of dopamine producing cells in the brain, the VTA degenerates at
a much slower rate compared to the SN. The slow degeneration preserves the
functionality associated with the VTA and fronto-striatal pathways, for example executive
functions or decision making. Additionally, exogenous L-Dopa may impair functions
related to the VTA and downward frontal projections. This pattern of degeneration and
effect of L-Dopa are the basis of the overdosing hypothesis.
To further support our claim in Chapter 2, that the dopaminergic system is involved in
regularity processing, we recruited healthy younger controls and tested them ON and OFF
L-Dopa in an fMRI/regularity processing paradigm to remove aging and PD as two
factors. We found that introducing L-Dopa reduced activity in the STG and left
hippocampus, although it did not reach statistical significance after multiple comparisons
correction. Yet, it is suggestive that a small dose of L-Dopa administered once in healthy
younger subjects may have influenced the brain activation associated with regularity
processing.

Attention effect on regularity processing.
Subjects performed optimally both ON and OFF medication during the active task
(Chapter 3), indicating that medication did not affect their performance. However, when
actively listening to the auditory stimuli, REG and RAND conditions were not
significantly different and medication did not have any effect on the neural activity.
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Despite the absence of a direct passive vs active comparison, there is evidence supporting
different networks in passive vs active processing.
In Chapter 3, we aimed to investigate the effects of attention on regularity processing. We
found that brain activity was not significantly different between REG and RAND when
subjects were attending to the auditory stimuli and responding to the change in its
structure. The similarity in the neural activity between these two stimuli suggests that
attention increases the predictability effect and thus reduces the surprise effect provoked
by RAND stimuli as seen during the passive listening task (Sohoglu & Chait, 2016;
Zhang & Rowe, 2015).
Although at odds with the general role of attention in auditory processing (Sussman et al.,
2007; Zhao & Luo, 2017), our study is consistent with observations from previous studies
that auditory regularities can be detected irrespective of the attentive state of the subject
(Schwartze et al., 2011; Sohoglu & Chait, 2016; Spratling, 2008). However, attention and
expectation would have affected the perception of the transition between regularity and
randomness because they become similar in terms of top-down processing. The main
difference, however, between our study and Sohoglu & Chait., (2016) is that in their study
the scene-evoked response (i.e., stimuli that did not transition from RAND to REG)
showed similar activation. In contrast, our study showed a preference to REG compared
to RAND stimuli in the passive condition but not in the active one (Barascud et al., 2016).
Which can be explained by the nature of the stimuli and the difference between the
temporal and spectral regularities that can target either the parietal
The relationship between the auditory system and gait is complicated. It is hypothesized
that the auditory system is highly involved in gait, evidenced by improvement in gait
outcomes following RAS, for example. Furthermore. evidence showing improvements in
gait upon the addition of an auditory cue (e.g., Hausdorff et al., 2007) in addition to other
findings (e.g., examining why we tap to a beat; Cameron, Pickett, Earhart, & Grahn,
2016; Grahn, 2009; Grahn & Brett, 2007; Grahn & Rowe, 2013)) suggest that there are
strong interactions between the auditory and motor systems, especially through the basal
ganglia. Moreover, several studies have shown an improvement in gait for healthy
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volunteers and PD patients, indicating a direct relation between the two systems (Erra et
al., 2019; Hausdorff et al., 2007; Mcintosh et al., 1997; Yu et al., 2015).
The loss of automaticity and automatic processing ability is not the sole underlying cause
of freezing in PD. The role of anxiety has been germane in explaining the
pathophysiology of freezing. However, there was little evidence for anxiety conclusively
playing a causal role in freezing, yet. Therefore, in our FOG study (Chapter 4), we
introduced a factor that reduces anxiety, which was expected to improve FOG and would
indicate whether anxiety was a causal factor for FOG in PD. More importantly, the results
from that study open the field of FOG treatment to other options, such as anxiolytics. To
better understand

FOG models
The prevailing theories that explain FOG encompass four models. The threshold model,
the interference model (cross-talk model), the cognitive model, and finally the decoupling
model. The threshold model (Plotnik et al., 2012) describes the accumulation of several
motor deficits, which when reaching a specific threshold, results in freezing. The
threshold model fits the freezing profile, especially when patients are turning, a motion
that requires a greater demand on locomotion and significant motor adjustments and most
of the time results in significant freezing. However, this model fails to explain the
upstream causes of FOG and neglects other factors that result in freezing, especially when
these factors are not “motor” related.
The cognitive model, as suggested by Vandenbossche et al in (2012) depicts the
incongruency between the intended actions and the actual actions, due to a conflict
resolution deficit as the main reason behind freezing. This model attributes freezing to the
loss of automatic processing ability (implicit mechanism such as set-shifting) and
consciously controlled mechanism. PD patients with FOG demonstrate a stronger
automatic activation of incorrect responses accompanied by a reduced efficiency in
suppressing conflicting responses during incongruent trials in inhibition task. Executive
function deficits are therefore the main risk for FOG and falls in this model. The
involvement of the fronto-striatal, STN, and inferior frontal cortex are central for action
selection and response inhibition. With a deficit in these circuits, in terms of the
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automaticity, freezing is bound to occur. Additionally, a significant BOLD response
reduction in the fronto-striatal areas was observed in FOG patients (Shine et al., 2013).
Therefore, faster decisions and greater incongruence is believed to induce FOG.
In contrast, Jacobs et al (2009), explained freezing as a result of decoupling between the
pre-planned motion and the executed one. Hence, a discrepancy or a malfunction in the
anticipatory postural adjustments with gait initiation or continuation results in the freezing
behaviour seen in PD. So, the decoupling model tackles freezing through looking at the
postural instability associated with PD and its effect on the gait cycle.
Lastly, the interference -or cross-talk- model suggests an overload of information from the
cognitive, motor, or limbic (or a combination of the three) circuits during performing
motor tasks such as walking. The interference model is dependent on the overflow of
information from the cognitive, motor, or limbic loops to the striatum which at a certain
point impairs the internal pallidal outflow thus inhibiting the pedunculopontine nucleus
(PPN) resulting in freezing (Lewis & Barker, 2009). Mainly, the striatum, an area
significantly depleted of dopamine, receives an inflow of information that it is unable to
process resulting in a disinhibition in the pallidal pathway, resulting in freezing.
Our study in Chapter 4 shows that provoking anxiety induces FOG, shown by the fact that
freezing only occurred during the HA scenarios. To further support the role anxiety plays
in FOG, reducing anxiety, using Alprazolam, resulted in a reduction in subjects who
experienced freezing. Moreover, reducing anxiety improved gait variables that were
highly correlated with FOG and chances of falling. Given that we were able to manipulate
anxiety by increasing it using virtual reality and reducing it using Alprazolam, we can say
that our study might be supported by the cross-talk model. The increase in limbic load via
higher anxiety worsened freezing and the later reduction improved freezing.

Limitations and future directions
In our first experiment, even though the effect is present in both PD patients and healthy
controls, we were not able to measure L-Dopa’s effect on the younger adults. However,
we were able to clearly establish an effect of the dopaminergic pathway on regularity
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processing in the auditory stream. The effect was more in line with the dopamine
overdose hypothesis with strong evidence favoring the VTA and its downward projections
on regularity processing. It is crucial in the future to perform the same study on healthy
younger controls both on and off L-Dopa. Testing younger adults on L-Dopa will support
our hypothesis on the role of the dopaminergic pathway in auditory regularity processing,
indicated by the EEG sustained response.
During the fMRI study, multiple participants were excluded due to scanner problems.
Additional participants were excluded because they had some expected adverse events
leading them to drop out of the study. Thus, the recruitment was lower than expected.
Additionally, due to time constraint and COVID restrictions, we were not able to scan PD
patients on that protocol, which partially weakened our interpretation of the role of the
dopamine system and striatum on regularity processing in PD. Future recommendations
are to include a larger sample size for younger adults. Also, a similar protocol should be
implemented in a group of healthy older controls and PD patients. This way we can tease
apart the role of aging and the dopaminergic system in regularity processing.
Finally, during our FOG study (chapter 4), it was challenging to recruit PD patients
experiencing freezing who were able to walk independently, did not have any
contraindication with alprazolam, did not have any problems with the virtual
environment, and who were willing to participate in our study. Furthermore, anxiety
reduction could have been more evident, but due to 1) the very low dose used in the study
(0.25mg), 2) the lack of sensitivity of the BAI questionnaire in detecting anxiety state
changes, and 3) the randomized order of the virtual scenarios (LA, HA-Pit, and HAPlank) might have diluted the captured anxiety scores. However, the results from this
study are an important steppingstone in promoting an alternative to reduce both anxiety
and FOG in PD. Different anxiolytics, which are more tolerable and with fewer side
effects, could be used. The use of cognitive behavioral therapy (a known anxiety reducing
technique) may also be of importance when investigating reducing anxiety and FOG in
PD. We would also suggest the usage of a more realistic virtual-anxiety scenarios (house
setting, for example), or a scenario with turns (which are a major freezing inducer).
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Conclusion
In conclusion, we were able to isolate brain activity (both via EEG and fMRI) linked to
auditory regularity processing in aging, PD, and with respect to dopaminergic medication.
We concluded that PD is as detrimental as aging when it comes to auditory regularity
processing. Negative effects of L-Dopa were found in younger controls (fMRI) and older
controls and PD patients (EEG study). Most importantly, our final study has shown a
possible treatment for FOG, which is disruptive to PD patients and significantly impairs
their quality of life.
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